Processing 00000000.tx.1: Distinct Roles for Gi2, Gi3, and G in Modulation of Forskolin- or Gs-mediated cAMP Accumulation and Calcium Mobilization by Dopamine D2S Receptors* Mohammad H. 

Phrase: "Distinct Roles for Gi2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "Gi3,"

Phrase: "and"

Phrase: "G in Modulation of Forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "Gs-mediated cAMP Accumulation"

Phrase: "and"

Phrase: "Calcium Mobilization by Dopamine D2S Receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596233:calcium mobilization [Cell Function]
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]

Phrase: "* Mohammad H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Ghahremani, Peihua Cheng, Paola M.C. 

Phrase: "Ghahremani,"

Phrase: "Peihua Cheng,"

Phrase: "Paola M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Lembo, and Paul R. 

Phrase: "Lembo,"

Phrase: "and"

Phrase: "Paul R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: Albert From the Department of Pharmacology and Therapeutics, McGill University, Montreal H3G 1Y6, Canada and the Neuroscience Research Institute, University of Ottawa, Ottawa K1H 8M5, Canada  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Previous studies have shown that a single G protein-coupled receptor can regulate different effector systems by signaling through multiple subtypes of heterotrimeric G proteins. 

Phrase: "Albert From the Department of Pharmacology"

Phrase: "and"

Phrase: "Therapeutics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]

Phrase: "McGill University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Montreal H3G 1Y6,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "and"

Phrase: "the Neuroscience Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "University of Ottawa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551454:Ottawa [Population Group]

Phrase: "Ottawa K1H 8M5,"

Phrase: "Canada  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a single G protein-coupled receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   840   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439267:g% [Quantitative Concept]
   804   C1948027:Coupled [Functional Concept]
   771 E C0010222:couple [Family Group]

Phrase: "can"

Phrase: "regulate"

Phrase: "different effector systems by signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "through multiple subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "of heterotrimeric G proteins."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752348:Heterotrimeric G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C1325335:heterotrimeric G-protein [Cell Component]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.5: In LD2S fibroblast cells, the dopamine D2S receptor couples to pertussis toxin (PTX)-sensitive Gi/Go proteins to inhibit forskolin- or prostaglandin E1-stimulated cAMP production and to stimulate calcium mobilization. 

Phrase: "In LD2S fibroblast cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0016030:fibroblast cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the dopamine D2S receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "couples to pertussis toxin (PTX)-sensitive Gi/"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   783   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C0010222:Couples [Family Group]
   753   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   753   C0043167:Pertussis [Disease or Syndrome]
   753   C1550474:sensitive [Idea or Concept]
   753   C1948027:Couple [Functional Concept]
   753   C3539617:GI [Idea or Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "proteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "prostaglandin E1-stimulated cAMP production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C1514503:Prostaglandin Production [Physiologic Function]
   804   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "calcium mobilization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596233:calcium mobilization [Cell Function]
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]
Processing 00000000.tx.6: To analyze the role of distinct Gi/o protein subtypes, LD2S cells were stably transfected with a series of PTX-insensitive Gi/o protein Cys Ser point mutants and assayed for D2S receptor signaling after PTX treatment. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the role of distinct Gi/o protein subtypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "of PTX-insensitive Gi/o protein Cys Ser point mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "assayed for D2S receptor signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1514762:Receptor Signaling [Molecular Function]
   760   C0037083:Signaling [Cell Function]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C3537152:signaling [Biologic Function]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "after PTX treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
Processing 00000000.tx.7: The level of expression of the transfected G mutant subunits was similar to the endogenous level of the most abundant Gi/o proteins (Go, Gi3). 

Phrase: "The level of expression of the transfected G mutant subunits"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C3244092:expression level [Idea or Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "similar to the endogenous level of the most abundant Gi/o proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C2348205:Similar [Qualitative Concept]

Phrase: "("

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Gi3"

Phrase: ")."
Processing 00000000.tx.8: D2S receptor-mediated inhibition of forskolin-stimulated cAMP production was retained only in clones expressing mutant Gi2. 

Phrase: "D2S receptor-mediated inhibition of forskolin-stimulated cAMP production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1514761:Receptor Inhibition [Cell Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "only in clones"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0009013:Clones [Cell]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756 E C1522642:Clone [Tissue]
   706 E C1704387:Clonal [Qualitative Concept]

Phrase: "expressing"

Phrase: "mutant Gi2."
Processing 00000000.tx.9: In contrast, the D2S receptor utilized Gi3 to inhibit PGE1-induced (Gs-coupled) enhancement of cAMP production. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "utilized"

Phrase: "Gi3 to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PGE1-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "(Gs-"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: ")"

Phrase: "enhancement of cAMP production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]
Processing 00000000.tx.10: Following stable or transient transfection, no single or pair set of mutant Gi/o subtypes rescued the D2S-mediated calcium response following PTX pretreatment. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]

Phrase: "or"

Phrase: "transient transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "no single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "or"

Phrase: "pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "set of mutant Gi/o subtypes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0036849:Set [Mental Process]
   753   C0449560:subtypes [Classification]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3539617:GI [Idea or Concept]

Phrase: "rescued"

Phrase: "the D2S-mediated calcium response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0870868:mediated response [Mental Process]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "PTX pretreatment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
Processing 00000000.tx.11: On the other hand, in LD2S cells stably transfected with GRK-CT, a receptor kinase fragment that specifically antagonizes G subunit activity, D2S receptor-mediated calcium mobilization was blocked. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "in LD2S cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with GRK-CT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872383:GRK [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3540513:CT [Gene or Genome]

Phrase: "a receptor kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that specifically"

Phrase: "antagonizes"

Phrase: "G subunit activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "D2S receptor-mediated calcium mobilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0596233:calcium mobilization [Cell Function]
   804   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   804   C0300926:mobilization [Functional Concept]

Phrase: "was"

Phrase: "blocked."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.12: The observed specificity of Gi2 and Gi3 for different states of adenylyl cyclase activation suggests a higher level of specificity for interaction of Gi subunits with forskolin- versus Gs-activated states of adenylyl cyclase than has been previously appreciated.  

Phrase: "The observed specificity of Gi2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "Gi3 for different states of adenylyl cyclase activation"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a higher level of specificity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "for interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "of Gi subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "with forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "versus"

Phrase: "Gs-activated states of adenylyl cyclase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1301808:states [Geographic Area]
   719 E C1442792:State [Functional Concept]
   719 E C3148680:State [Geographic Area]

Phrase: "than"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "appreciated."
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES A wide variety of physiological functions and pathological conditions are regulated by hormones and neurotransmitters which transduce intracellular signals by coupling to heterotrimeric guanine nucleotide-binding proteins (G proteins).1 Upon receptor activation, G proteins dissociate into G and G subunits which in turn regulate the activity of effector molecules (1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A wide variety of physiological functions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "pathological conditions"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "regulated by hormones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0019932:Hormones [Hormone]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   706 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "neurotransmitters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "which"

Phrase: "transduce"

Phrase: "intracellular signals by coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "to heterotrimeric guanine nucleotide-binding proteins"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   904   C0086376:Guanine Nucleotide Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0596637:guanine nucleotide binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1817325:guanine binding [Molecular Function]
   840   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1148916:nucleotide binding [Molecular Function]
   804   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "(G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: ").1 Upon receptor activation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1514758:Receptor Activation [Cell Function]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1879547:Activation [Activity]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "dissociate into G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "G subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "regulate"

Phrase: "the activity of effector molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: The family of G subunits is divided into structural and functional homologues, for example, Gs proteins couple positively to AC to increase intracellular production of cAMP; 

Phrase: "The family of G subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "is"

Phrase: "divided into structural"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332849:Divided [Functional Concept]
   790   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional homologues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Gs proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "positively to AC to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1412573:AC [Gene or Genome]
   770   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3539770:AC [Gene or Genome]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular production of cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: ";"
Processing 00000000.tx.15: Gi/o proteins couple negatively to AC and are inactivated by PTX; 

Phrase: "Gi/o proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "negatively to AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1412573:AC [Gene or Genome]
   790   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3539770:AC [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "inactivated by PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.16: and Gq proteins couple to PLC- subtypes to increase [Ca2+]i and are insensitive to PTX. 

Phrase: "and"

Phrase: "Gq proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0767337:Gq Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "couple to PLC- subtypes to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010222:couple [Family Group]
   760   C0449560:subtypes [Classification]
   760   C1948027:Couple [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "are"

Phrase: "insensitive to PTX."
Processing 00000000.tx.17: The G subunits of G proteins couple to a variety of cell-specific effectors including AC types II and IV, PLC-2 and PLC-3, inwardly rectifying potassium channels, and N-type calcium channels (4, 5). 

Phrase: "The G subunits of G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "couple to a variety of cell-specific effectors"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   750   C0312740:Effector Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0010222:couple [Family Group]
   744   C0205369:Specific [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1552740:specific [Intellectual Product]
   744   C1704653:Cell [Medical Device]
   744   C1883525:Variety [Conceptual Entity]
   744   C1948027:Couple [Functional Concept]
   744   C1948049:Cell [Spatial Concept]
   744   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "AC types II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C0441730:Type II [Classification]

Phrase: "and"

Phrase: "IV,"

Phrase: "PLC-2"

Phrase: "and"

Phrase: "PLC-3,"

Phrase: "inwardly"

Phrase: "rectifying"

Phrase: "potassium channels,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032824:Potassium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032821:Potassium [Element, Ion, or Isotope]
   861   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "N-type calcium channels"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752246:N-type calcium channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   988 E C3538944:N-type calcium channel [Molecular Function]
   861   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C2936886:Calcium [Pharmacologic Substance]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: In addition, G protein-coupled receptors appear to utilize particular combinations of subunits to initiate specific types of responses (6). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "G protein-coupled receptors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "utilize"

Phrase: "particular combinations of subunits to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "specific types of responses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.19: The dopamine D2S receptor couples to PTX-sensitive G proteins (Gi/o) to initiate multiple signaling pathways (7, 8). 

Phrase: "The dopamine D2S receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "couples to PTX-sensitive G proteins"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   778   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0332324:Sensitive to [Functional Concept]
           Sensitive
   757 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   748   C0010222:Couples [Family Group]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C0043167:Pertussis [Disease or Syndrome]
   748   C0439267:g% [Quantitative Concept]
   748   C1550474:sensitive [Idea or Concept]
   748   C1948027:Couple [Functional Concept]

Phrase: "(Gi/o) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539617:GI [Idea or Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "multiple signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.20: In cells of neuroendocrine origin the D2S couples to "inhibitory" pathways, including inhibition of adenylyl cyclase, activation of potassium channels to hyperpolarize the cell membrane, and inhibition of L-type calcium channels (9-12), which in concert mediate inhibition of hormone secretion and gene transcription, and inhibition of cell proliferation (13-18). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "of neuroendocrine origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "the D2S"

Phrase: "couples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:Couples [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "to ""inhibitory"" pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "inhibition of adenylyl cyclase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "activation of potassium channels to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "hyperpolarize"

Phrase: "the cell membrane,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "inhibition of L-type calcium channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1516145:Calcium Channel Inhibition [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "(9-12"

Phrase: ")"

Phrase: ","

Phrase: "which in concert"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inhibition of hormone secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2250376:inhibition of hormone secretion [Cell Function]
   881   C2259158:inhibition of secretion [Cell Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "gene transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "inhibition of cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1156236:Inhibition of Cell Proliferation [Cell Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "(13-18"

Phrase: ")."
Processing 00000000.tx.21: By contrast, when expressed in cells of mesenchymal lineage (e.g. Ltk fibroblast or Chinese hamster ovary cells), the same receptor mediates stimulation of phospholipase C activity to induce calcium mobilization, and activation of the mitogen-activated protein kinase cascade leading to enhanced gene transcription and cell proliferation (8, 14, 17, 19-23). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "expressed in cells of mesenchymal lineage"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C0282637:Cell Lineage [Idea or Concept]
   767   C1257975:Mesenchymal cell [Cell]
   753   C0007634:Cells [Cell]
   753   C1513143:Mesenchymal [Qualitative Concept]
   753   C1881379:Lineage [Conceptual Entity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "e.g. Ltk fibroblast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblast [Cell]

Phrase: "or"

Phrase: "Chinese hamster ovary cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "the same receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "stimulation of phospholipase C activity to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "calcium mobilization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596233:calcium mobilization [Cell Function]
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]

Phrase: "and"

Phrase: "activation of the mitogen-activated protein kinase cascade"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1819041:protein kinase activation [Cell Function]
   789   C3156336:protein activation cascade [Molecular Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]
   703   C0752319:mitogen-activated protein kinase cascade [Molecular Function]

Phrase: "leading to enhanced gene transcription"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0040649:Gene Transcription [Genetic Function]
           Transcription
   760   C0017337:Gene [Gene or Genome]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(8,"

Phrase: "14,"

Phrase: "17,"

Phrase: "19-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: These findings suggest that the same receptor mediates different cellular responses depending on the repertoire of cell-specific effectors that are expressed. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the same receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "different cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "depending on the repertoire of cell-specific effectors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C0312740:Effector Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0205369:Specific [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1552740:specific [Intellectual Product]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711   C0725813:depend [Medical Device]

Phrase: "that"

Phrase: "are"

Phrase: "expressed."
Processing 00000000.tx.23: To address the pathways that underlie cell-specific signaling we have studied the G protein specificity of D2S receptor coupling, based on the hypothesis that different G protein subunits mediate receptor coupling to inhibitory versus stimulatory signaling events. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "underlie"

Phrase: "cell-specific signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0037083:Cell Signaling [Cell Function]
           Signaling
   827   C3537152:signaling [Biologic Function]

Phrase: "we"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the G protein specificity of D2S receptor coupling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]

Phrase: "based on the hypothesis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that different G protein subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   779   C1711351:Subunit [Quantitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "receptor coupling to inhibitory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0597359:receptor coupling [Molecular Function]
   770   C1948027:Coupling [Functional Concept]

Phrase: "versus"

Phrase: "stimulatory signaling events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
Processing 00000000.tx.24: PTX acts to uncouple Gi/o proteins by ADP-ribosylating these subunits at a conserved carboxyl-terminal domain cysteine (Cys) residue (24). 

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "acts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "uncouple"

Phrase: "Gi/o proteins by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ADP-ribosylating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0523452:ADP [Laboratory Procedure]

Phrase: "these subunits at a conserved carboxyl-terminal domain cysteine (Cys) residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1711351:Subunit [Quantitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.25: By mutating the conserved Cys residue in Gi1, Gi2, Gi3, and Go to a ribosylation-resistant serine (Ser) residue we have generated a series of PTX-insensitive mutants of Gi/o protein (G-PTX). 

Phrase: "By mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "the conserved Cys residue in Gi1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "Gi2,"

Phrase: "Gi3,"

Phrase: "and"

Phrase: "Go to a ribosylation-resistant serine (Ser) residue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1709915:Residue [Conceptual Entity]
   748   C1822658:GO [Gene or Genome]
   748   C1882936:RESIDUE [Phenomenon or Process]
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a series of PTX-insensitive mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "of Gi/o protein (G-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   799   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   799   C0043167:Pertussis [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.26: Because the Cys Ser mutation is a structurally conservative change, the mutant G proteins remain functional following PTX pretreatment (25-28). 

Phrase: "Because"

Phrase: "the Cys Ser mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a structurally conservative change,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "the mutant G proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "remain"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "PTX pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "(25-28"

Phrase: ")."
Processing 00000000.tx.27: We have assessed the contribution of individual or specific combinations of G protein subunits to D2S-mediated signaling. 

Phrase: "We"

Phrase: "have"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the contribution of individual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "or"

Phrase: "specific combinations of G protein subunits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0453882:Combinations [Manufactured Object]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "to D2S-mediated signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
Processing 00000000.tx.28: The D2S receptor utilizes distinct single G subunits to inhibit cAMP accumulation depending on the method of AC activation. 

Phrase: "The D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "utilizes"

Phrase: "distinct single G subunits to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1711351:Subunit [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cAMP accumulation"

Phrase: "depending on the method of AC activation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1412573:AC [Gene or Genome]
   748   C1879547:Activation [Activity]
   748   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3539770:AC [Gene or Genome]
   714   C0725813:depend [Medical Device]
Processing 00000000.tx.29: In contrast, calcium mobilization induced by the D2S receptor is not reconstituted with single or combinations of G subunits, but is blocked by inhibiting G function. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "calcium mobilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596233:calcium mobilization [Cell Function]
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]

Phrase: "induced by the D2S receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induced [Functional Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reconstituted with single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0037179:Single [Population Group]
   790   C0087136:single [Finding]
   790   C0205171:Single [Quantitative Concept]

Phrase: "or"

Phrase: "combinations of G subunits,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0453882:Combinations [Manufactured Object]
   737 E C0205195:Combination [Qualitative Concept]
   737 E C1947911:Combination [Physical Object]

Phrase: "but"

Phrase: "is"

Phrase: "blocked by inhibiting G function."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0028778:Blocked [Pathologic Function]
   760   C0031843:function [Physiologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0439267:g% [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   760   C2983591:BLOCKED [Research Activity]
   760   C3463820:Inhibiting [Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.30: These results indicate a strong dependence on Gi subtype for D2S-mediated inhibition of AC that is not observed for stimulation of calcium mobilization.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "a strong dependence on Gi subtype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "for D2S-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed for stimulation of calcium mobilization."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0596233:calcium mobilization [Cell Function]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
   753   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.31: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- Apomorphine, dopamine, EGTA, forskolin, PGE1, isobutylmethylxanthine, and PTX were from Sigma. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Apomorphine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003596:Apomorphine [Organic Chemical,Pharmacologic Substance]

Phrase: "dopamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "PGE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "isobutylmethylxanthine,"

Phrase: "and"

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.32: Fura 2-AM was purchased from Molecular Probes (Eugene, OR) and hygromycin B from Calbiochem. 

Phrase: "Fura 2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "AM"

Phrase: "was"

Phrase: "purchased from Molecular Probes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0182400:Probes [Medical Device]
   770   C0869011:purchased [Activity]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "(Eugene,"

Phrase: "OR)"

Phrase: "and"

Phrase: "hygromycin B from Calbiochem."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   770   C0063201:hygromycin [Organic Chemical]
Processing 00000000.tx.33: 125I-Succinyl cAMP and polyvinylpyrrolidone membrane were from NEN Life Science Products Inc. and [-32P]dCTP and ECL Western blot detection kits were from Amersham Corp. 

Phrase: "125I-Succinyl cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "polyvinylpyrrolidone membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "were from NEN Life Science Products Inc."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   814   C0332070:Life Science Products [Health Care Related Organization]
   778   C0005526:Science, Life [Occupation or Discipline]
   748   C0036397:Science [Occupation or Discipline]
   748   C0376558:Life [Idea or Concept]
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "and [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ECL Western blot detection kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C1690540:Kits [Qualitative Concept]
   771 E C0812225:KIT [Medical Device]
   771 E C1150635:KIT [Molecular Function]
   771 E C1705212:Kit [Medical Device]
   771 E C1705213:KIT [Medical Device]
   771 E C3273202:Kit [Manufactured Object]

Phrase: "were from Amersham Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0683758:Corp. [Organization]
Processing 00000000.tx.34: Sera, media, and Geneticin (G418) were obtained from Life Technologies, Inc. 

Phrase: "Sera,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0229671:Sera [Body Substance]
  1000   C1151254:SerA [Molecular Function]
   966 E C1546774:Serum [Intellectual Product]
   966 E C1550100:Serum [Body Substance]

Phrase: "media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "Geneticin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119053:Geneticin [Organic Chemical,Pharmacologic Substance]

Phrase: "(G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Life Technologies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.35: Plasmids pY3 and pCMV-LacZ II were obtained from the American Type Culture Collection (Manassas, VA). 

Phrase: "Plasmids pY3"

Phrase: "and"

Phrase: "pCMV-LacZ II"

Phrase: "were"

Phrase: "obtained from the American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   853   C0598079:American Type Culture Collection [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0596070:American [Population Group]
   748   C1301820:Obtained [Functional Concept]
   748   C1516698:Collection [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704814:Collection [Idea or Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1706701:Obtain [Activity]

Phrase: "(Manassas,"

Phrase: "VA)."
Processing 00000000.tx.36: Endonucleases and DNA polymerase were purchased from New England Biolabs (Mississauga, Ontario, Canada). 

Phrase: "Endonucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014230:Endonucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "purchased from New England Biolabs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0869011:purchased [Activity]

Phrase: "(Mississauga,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.37: Taq polymerase has been purchased from Pharmacia Biotech Inc. 

Phrase: "Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "purchased from Pharmacia Biotech Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.38: (Baie d'Urfe, QB). 

Phrase: "(Baie"

Phrase: "d'"

Phrase: "Urfe,"

Phrase: "QB"

Phrase: ")."
Processing 00000000.tx.39: The cDNAs encoding wild-type rat Go, Gi1, Gi2, and Gi3 were generously provided by Dr. 

Phrase: "The cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "wild-type rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034693:Wild rat [Mammal]
           Rat, NOS
   827   C0034721:Rat [Mammal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Gi1,"

Phrase: "Gi2,"

Phrase: "and"

Phrase: "Gi3"

Phrase: "were"

Phrase: "generously"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.40: Randall Reed, Johns Hopkins University, Baltimore, MD. 

Phrase: "Randall Reed,"

Phrase: "Johns Hopkins University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD."
Processing 00000000.tx.41: The Go antibody was from Santa Cruz Biotechnology Inc. 

Phrase: "The"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Santa Cruz Biotechnology Inc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.42: (Santa Cruz, CA) and anti-Gi1-2 and anti-Gi3 were obtained from Calbiochem (San Diego, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)"

Phrase: "and"

Phrase: "anti-Gi1-2"

Phrase: "and"

Phrase: "anti-Gi3"

Phrase: "were"

Phrase: "obtained from Calbiochem"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.43: Anti-RGS-His6 was purchased from Qiagen (Santa Clarita, CA). 

Phrase: "Anti-RGS-His6"

Phrase: "was"

Phrase: "purchased from Qiagen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Santa Clarita,"

Phrase: "CA)."
Processing 00000000.tx.44: Cell Culture-- Murine Ltk cells stably transfected with rat dopamine D2S receptor (LD2S) (13) were maintained in minimum Eagle's medium (MEM) with 10% FBS in a humidified atmosphere of 5% CO2, 95% air at 37C. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Murine Ltk cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with rat dopamine D2S receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(LD2S"

Phrase: ")"

Phrase: "(13"

Phrase: ")"

Phrase: "were"

Phrase: "maintained in minimum Eagle's medium (MEM)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0009458:Medium [Intellectual Product]
   760   C0325564:Eagle [Bird]
   760   C0439536:Medium [Quantitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1524031:Minimum [Qualitative Concept]
   760   C1551720:Eagle [Population Group]
   760   C1552614:minimum [Idea or Concept]
   760   C1705217:Medium [Substance]
   760   C2826545:MINIMUM [Quantitative Concept]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "with 10% FBS"

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "of 5% CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "95% air at 37C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001861:Air [Substance]
   770   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.45: The cells were routinely passaged using 0.05% trypsin, 0.02% EDTA in HBBS. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "routinely passaged"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.05% trypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "0.02% EDTA in HBBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: For PTX treatment, the cells were treated with 50ng/ml PTX for 16h prior to experimentation. 

Phrase: "For PTX treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 50ng/ml PTX"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   753   C0043167:Pertussis [Disease or Syndrome]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 16h"

Phrase: "prior to experimentation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678323:experimentation [Research Activity]
Processing 00000000.tx.47: Site-directed Mutagenesis-- Site-directed mutagenesis was performed using the Altered Sites IITM system (Promega). 

Phrase: "Site-directed Mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "--"

Phrase: "Site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Altered Sites IITM system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.48: PTX-insensitive Gi/o mutants were generated using rat cDNAs (29) encoding Go, Gi1, Gi2, and Gi3 subunits. 

Phrase: "PTX-insensitive Gi/o mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(29"

Phrase: ")"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Gi1,"

Phrase: "Gi2,"

Phrase: "and"

Phrase: "Gi3 subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.49: The cysteine 351codon (352for Gi2), i.e. 

Phrase: "The cysteine 351codon"

Phrase: "(352for Gi2"

Phrase: ")"

Phrase: ","

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.50: TGT, was mutated to TCT in order to encode serine using the following oligonucleotides: Go-PTX, TCCGGGGCTCTGGCTTGTA; 

Phrase: "TGT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421391:TGT [Gene or Genome]
  1000   C1428265:TGT [Gene or Genome]

Phrase: "was"

Phrase: "mutated to TCT"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0677634:TCT [Laboratory Procedure]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "TCCGGGGCTCTGGCTTGTA"

Phrase: ";"
Processing 00000000.tx.51: Gi1-PTX, AACCTAAAAGACTCTGGTC; 

Phrase: "Gi1-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "AACCTAAAAGACTCTGGTC"

Phrase: ";"
Processing 00000000.tx.52: Gi2-PTX, ACAACCTGAAGGACTCTGGC, and Gi3-PTX, AAGGAATCTGGGCTTTACT. 

Phrase: "Gi2-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "ACAACCTGAAGGACTCTGGC,"

Phrase: "and"

Phrase: "Gi3-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "AAGGAATCTGGGCTTTACT."
Processing 00000000.tx.53: The mutation was confirmed by endonuclease restriction analysis and Sanger dide- oxynucleotide sequencing. 

Phrase: "The mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "confirmed by endonuclease restriction analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   797   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443288:Restriction [Functional Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "Sanger dide- oxynucleotide sequencing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1511897:Sanger Sequencing [Molecular Biology Research Technique]
   812   C1553778:Sequencing [Intellectual Product]
   812   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.54: The mutant cDNAs were then subcloned into the EcoRI site of the pcDNA3 (Invitrogen) mammalian expression vector under control of the cytomegalovirus promoter. 

Phrase: "The mutant cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "then subcloned into the EcoRI site of the pcDNA3"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "mammalian expression vector under control of the cytomegalovirus promoter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0031249:control vector [Occupational Activity]
   742   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0442335:Vector [Spatial Concept]
   742   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.55: His-GRK-CT Construct-- The OK-GRK2 cDNA (30) was partially digested with BbsI and EcoRI endonuclease and the 1506-bp fragment encoding the COOH-terminal domain starting from Thr493 was isolated and used for the construct (GRK-CT). 

Phrase: "His-GRK-CT Construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "-"

Phrase: "-"

Phrase: "The OK-GRK2 cDNA (30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "partially"

Phrase: "digested with BbsI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "EcoRI endonuclease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011516:EcoRI Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the 1506-bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the COOH-terminal domain starting from Thr493"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0439659:Start [Temporal Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "used for the construct"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C2827421:Construct [Classification]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(GRK-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.56: The His-tag was incorporated using the following complementary oligonucleotides: 5'-CACCATGCGAGGTAGTCACCACCACCACCACCACAC-3' and 5'-CTTTGTGTGGTGGTGGTGGTGGTGACTACCTCGCATGGTGGTAC-3'. 

Phrase: "The"

Phrase: "His-tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037293:Tag [Neoplastic Process]
  1000   C0181496:Tag [Manufactured Object]
  1000   C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "incorporated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following complementary oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5'-CACCATGCGAGGTAGTCACCACCACCACCACCACAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CTTTGTGTGGTGGTGGTGGTGGTGACTACCTCGCATGGTGGTAC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.57: The two oligonucleotides were designed to encode Met-Arg-Gly-Ser-His6 with a Kozak sequence (31) in the NH2-terminal and cohesive KpnI site at the 5' end and a BbsI site at the 3' end. 

Phrase: "The two oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "Met-Arg-Gly-Ser-His6 with a Kozak sequence"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "in the NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0002508:NH2 [Organic Chemical]
   861   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "cohesive KpnI site at the 5' end"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a BbsI site at the 3' end."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.58: The oligonucleotides were annealed and ligated to GRK-CT fragment using BbsI-cohesive end (His-GRK-CT) and the His-GRK-CT fragment was cloned in pcDNA3 mammalian expression vector in KpnI/EcoRI site. 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "annealed"

Phrase: "and"

Phrase: "ligated to GRK-CT fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332255:fragment [Functional Concept]
   760   C0872383:GRK [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1708096:Fragment [Qualitative Concept]
   760   C3540513:CT [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BbsI-cohesive end ("
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0444930:End [Spatial Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "His-GRK-CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "the His-GRK-CT fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned in pcDNA3 mammalian expression vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009013:cloned [Cell]
   753   C0024660:Mammalian [Mammal]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "in KpnI/EcoRI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.59: The structure of the His-GRK-CT construct was confirmed by DNA sequencing. 

Phrase: "The structure of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]

Phrase: "His-GRK-CT construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "confirmed by DNA sequencing."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.60: Stable Transfection-- LD2S cells plated at 50% confluence were co-transfected with 30g each of the mutant G subunit constructs (Go-PTX, Gi1-PTX, Gi2-PTX, and Gi3-PTX) and 2g of pY3 using the calcium phosphate co-precipitation method (32) and cultured in MEM, 10% FBS containing 400g/ml hygromycin-B for 2-3 weeks. 

Phrase: "Stable Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "plated at 50% confluence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "co-transfected with 30g"

Phrase: "each of the mutant G subunit constructs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0439267:g% [Quantitative Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1457900:Each [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   714   C2827421:Construct [Classification]

Phrase: "("

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi1-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi2-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "Gi3-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "2g of pY3"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium phosphate co-precipitation method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in MEM, 10% FBS containing 400g/ml hygromycin-B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   791   C0063201:hygromycin [Organic Chemical]

Phrase: "for 2-3 weeks."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442457:2 Weeks [Temporal Concept]
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]
   734   C1519042:2-3 [Research Activity]
Processing 00000000.tx.61: Antibiotic-resistant clones of each transfection were picked (24clones/transfection) and tested for the expression of corresponding G proteins using Northern blot analysis. 

Phrase: "Antibiotic-resistant clones of each transfection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0009013:Clones [Cell]
   719 E C1522642:Clone [Tissue]

Phrase: "were"

Phrase: "picked"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1707391:Picked [Activity]
   966 E C1826583:PICK [Gene or Genome]

Phrase: "(24clones/transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: ")"

Phrase: "and"

Phrase: "tested for the expression of corresponding G proteins"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   750 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   750   C0788300:proteins test [Medical Device]
   750   C1171362:expression protein [Genetic Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0392366:tested [Intellectual Product]
   744   C0439267:g% [Quantitative Concept]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Northern blot analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]
Processing 00000000.tx.62: Transient Transfection-- Ltk cells were plated at 30-40% confluent on 15-cm plates with MEM+10% FBS. 

Phrase: "Transient Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at 30-40% confluent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205200:Confluent [Qualitative Concept]
   760   C0439509:/40 [Temporal Concept]
   726   C0005971:Plate [Medical Device]
   726   C1139930:plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]

Phrase: "on 15-cm"

Phrase: "plates with MEM+10% FBS."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0005971:Plate [Medical Device]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1139930:plate [Medical Device]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   760   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.63: The cells were co-transfected with D2S-pcDNA3 using individual G subunit (Go-PTX, Gi1-PTX, Gi2-PTX, and Gi3-PTX) mutant constructs (30or 60g) or the combination of two G proteins (Go/Gi1, Go/Gi2, Go/Gi3, Gi1/Gi2, Gi1/Gi3, and Gi2/Gi3; 30g/construct) and pCMV-LacZII (2g) using DEAE-dextran (33). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with D2S-pcDNA3"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "individual G subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "("

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi1-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi2-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "Gi3-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ")"

Phrase: "mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "(30or 60g"

Phrase: ")"

Phrase: "or"

Phrase: "the combination of two G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "("

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "/Gi1,"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "/Gi2,"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "/Gi3,"

Phrase: "Gi1/Gi2,"

Phrase: "Gi1/Gi3,"

Phrase: "and"

Phrase: "Gi2/Gi3"

Phrase: "; 30g/construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "pCMV-LacZII"

Phrase: "(2g"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DEAE-dextran"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011051:DEAE-Dextran [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   861   C0046079:DEAE [Organic Chemical,Pharmacologic Substance]
   861   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.64: Briefly, 1volume (40l) of DNA in TBS was added dropwise to 2volumes of DEAE-dextran (10mg/ml) in TBS with agitation. 

Phrase: "Briefly,"

Phrase: "1volume"

Phrase: "(40l"

Phrase: ")"

Phrase: "of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "dropwise to 2volumes of DEAE-dextran"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011051:DEAE-Dextran [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   753   C0046079:DEAE [Organic Chemical,Pharmacologic Substance]
   753   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "(10mg/ml) in TBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "with agitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]
Processing 00000000.tx.65: The mixture was added dropwise to plates containing 12ml of MEM+1% FBS and the plates were incubated for 4h at 37C, 5% CO2. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "dropwise to plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1139930:plates [Medical Device]
   756 E C0005971:Plate [Medical Device]
   756 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "12ml of MEM+1% FBS"

Phrase: "and"

Phrase: "the plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated for 4h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292426:4H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C,"

Phrase: "5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.66: The medium was aspirated and the cells were incubated in phosphate-buffered saline (136mM NaCl, 2.68mM KCl, 0.01mM Na2HPO4, 1.78M KH2PO4, pH 7.4) with 10% dimethyl sulfoxide for 1min. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in phosphate-buffered saline"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(136mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "2.68mM KCl,"

Phrase: "0.01mM Na2HPO4,"

Phrase: "1.78M KH2PO4,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "with 10% dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "for 1min."
Processing 00000000.tx.67: The plates were rinsed with phosphate-buffered saline and incubated in MEM+10% FBS. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "rinsed with phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in MEM+10% FBS."
Processing 00000000.tx.68: After 36-48 h, the transfected cells were assayed for intracellular free calcium and -galactosidase activity. 

Phrase: "After 36-48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "assayed for intracellular free calcium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   883   C0201579:Intracellular free calcium assay [Laboratory Procedure]
   806   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "and -"

Phrase: "galactosidase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150051:galactosidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.69: -Galactosidase Measurement-- A 100-l portion (10%) of the transfected cells was resuspended in 100l of Reporter Lysis Buffer (Promega), incubated for 15min at room temperature, centrifuged (14,000rpm, 20s) and the supernatant recovered. 

Phrase: "-Galactosidase Measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A 100-l portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449719:Portion [Spatial Concept]

Phrase: "(10%"

Phrase: ")"

Phrase: "of the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "resuspended in 100l of Reporter Lysis Buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1536403:lysis [Cell Function]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature, centrifuged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0179834:centrifuge [Medical Device]
   734   C2348236:ROOM TEMPERATURE [Qualitative Concept]

Phrase: "(14,"

Phrase: "000rpm,"

Phrase: "20s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552134:20s [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "recovered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]
Processing 00000000.tx.70: Equal volumes (30l each) of cell extract and substrate (0.3M 4-methylumbelliferyl -D-galactoside, 15mM Tris, pH 8.8) were mixed and incubated in the dark at 37 C for 15min. 

Phrase: "Equal volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449468:volumes [Quantitative Concept]
   827 E C1690016:% volume [Qualitative Concept]
   827 E C1705102:Volume [Intellectual Product]
   827 E C2700258:Volume [Laboratory Procedure]

Phrase: "(30l"

Phrase: "each"

Phrase: ")"

Phrase: "of cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(0.3M 4-methylumbelliferyl -"

Phrase: "D-"

Phrase: "galactoside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016956:galactoside [Carbohydrate]

Phrase: "15mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "were"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "incubated in the dark"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332582:Dark [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C"

Phrase: "for 15min."
Processing 00000000.tx.71: The reaction was terminated by addition of 50l of Stop solution (300mM glycine, 15mM EDTA, pH 11.2). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by addition of 50l of Stop solution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C1553404:terminated [Idea or Concept]
   744   C1883712:Addition [Functional Concept]
   744   C1947925:Stop [Activity]
   744   C2348570:Terminated [Functional Concept]
   744   C2746065:Stop [Temporal Concept]

Phrase: "(300mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "15mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 11.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.72: Samples were transferred to 2ml of Z buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4) and fluorescence was measured at EX=350nm, EM=450nm in a Perkin-Elmer LS-50 spectrofluorometer (Buckinghamshire, United Kingdom). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred to 2ml of Z buffer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0348011:transferred [Functional Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(60mM Na2HPO4,"

Phrase: "40mM NaH2PO4,"

Phrase: "10mM KCl,"

Phrase: "1mM MgSO4"

Phrase: ")"

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at EX=350nm,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "EM=450nm in a Perkin-Elmer LS-50 spectrofluorometer"

Phrase: "(Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.73: The transfection efficiencies differed by <10%. 

Phrase: "The transfection efficiencies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:efficiencies [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   777 E C0442799:Efficient [Qualitative Concept]

Phrase: "differed by"

Phrase: "<10%."
Processing 00000000.tx.74: Western Blot Analysis-- Cells (107/10-cm plate) were harvested and resuspended in 200l of RIPA-L buffer (10mM Tris, pH 8,1.5mM MgCl2, 5mM KCl, 0.5mM dithiothreitol, 0.5mM phenylmethylsulfonyl fluoride, 1% Nonidet P-40, 1% sodium lauryl sulfate, 0.5% sodium deoxycholate, 5g/ml leupeptin) on ice. 

Phrase: "Western Blot Analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(107/10-cm plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "resuspended in 200l of RIPA-L buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0034584:RIPA [Laboratory Procedure]

Phrase: "(10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5mM KCl,"

Phrase: "0.5mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1% sodium lauryl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Lauryl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:lauryl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "0.5% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "5g/ml leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.75: The cell lysate was then passed through a G-25 needle three times to shear genomic DNA and incubated on ice. 

Phrase: "The cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "passed through a G-25 needle three times"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0027551:Needle [Medical Device]
   744   C0040223:times [Temporal Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C1632851:Times [Quantitative Concept]
   744   C1704318:Needle [Medical Device]
   744   C1882041:Needle [Spatial Concept]
   744   C2828386:Passed [Finding]
   711 E C3541383:Time [Temporal Concept]

Phrase: "to shear genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "incubated on ice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.76: After 30min, the lysate was centrifuged (10,000g, 10min, 4C) and the supernatant recovered and assayed for protein content by the bicinchonic acid protein assay kit (Pierce). 

Phrase: "After 30min,"

Phrase: "the lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(10,"

Phrase: "000g,"

Phrase: "10min,"

Phrase: "4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "assayed for protein content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "by the bicinchonic acid protein assay kit (Pierce"

Phrase: ")."
Processing 00000000.tx.77: Lysates (100g/lane) were electrophoresed on sodium lauryl sulfate-containing 12% polyacrylamide gels at 100V, 40mA for 1h, blotted on polyvinylpyrrolidone membranes for 1h at 250mA at 4C. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "(100g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "electrophoresed on sodium lauryl sulfate-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0037506:Sodium Lauryl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   806   C0058632:lauryl sulfate [Lipid,Pharmacologic Substance]
   797   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C3536965:SULFATE [Element, Ion, or Isotope]
   726   C0013855:electrophorese [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "12% polyacrylamide gels at 100V,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   726 E C1382104:Gel [Substance]

Phrase: "40mA for 1h,"

Phrase: "blotted on polyvinylpyrrolidone membranes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C0032856:Polyvinyl pyrrolidone [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C2826070:Polyvinylpyrrolidone [Organic Chemical,Pharmacologic Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 250mA"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.78: Blots were incubated overnight in 5% nonfat dry milk in TBS-T (10mM Tris, 150mM NaCl, pH 8.0,0.05% Tween 20) at 4C. 

Phrase: "Blots"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight in 5% nonfat dry milk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0011682:Dry [Natural Phenomenon or Process]
   753   C0026131:Milk [Body Substance]
   753   C0205222:Dry [Qualitative Concept]
   753   C0349374:Milk [Food]
   753   C0439583:Overnight [Temporal Concept]
   753   C0444318:Milk [Substance]
   753   C1512080:Dry [Qualitative Concept]
   753   C2825079:Milk [Food]

Phrase: "in TBS-T (10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.05% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.79: The blots were then incubated for 1h with primary antibody, followed by a 30-min incubation with horseradish peroxidase-conjugated secondary antibody at room temperature in TBS-T, and the peroxidase product was developed using the ECL for Western blot protocol. 

Phrase: "The blots"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "with primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by a 30-min incubation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with horseradish peroxidase-conjugated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in TBS-T,"

Phrase: "and"

Phrase: "the peroxidase product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL for Western blot protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1332684:ECL [Gene or Genome]
Processing 00000000.tx.80: Reverse Transcriptase PCR-- Total RNA was extracted from mouse brain tissue and LD2S cells using guanidium acetate and reverse-transcribed using SuperScript II RNase H reverse transcriptase (Life Technologies Inc., Burlington, ON) and random hexamer primers (50ng). 

Phrase: "Reverse Transcriptase PCR-- Total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0599161:Reverse Transcriptase PCR [Molecular Biology Research Technique]

Phrase: "was"

Phrase: "extracted from mouse brain tissue"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0440746:Brain tissue [Tissue]
   806   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   806   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0040300:Tissue [Tissue]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1547928:Tissue [Intellectual Product]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "guanidium acetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "-"

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperScript II RNase H reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1555029:Reverse [Idea or Concept]
   799   C2257077:transcriptase [Genetic Function]

Phrase: "(Life Technologies Inc.,"

Phrase: "Burlington,"

Phrase: "ON)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720176:On [Functional Concept]
  1000   C1720294:On [Intellectual Product]

Phrase: "and"

Phrase: "random hexamer primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(50ng"

Phrase: ")."
Processing 00000000.tx.81: The cDNAs were subjected to PCR with the following primer pairs (2pmol/l) designed using Primer Select program (DNASTAR Inc.) to amplify specific fragments of different AC subtypes (AC I-VI) with the indicated sizes (bp): ACI (444), 5'-CTGCGGGCGTGCGATGAGGA-GTTC and 5'-GCGCACGGGCAGCAGGGCATAG; 

Phrase: "The cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "subjected to PCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with the following primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "(2pmol/l)"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "(DNASTAR Inc.) to"

Phrase: "amplify"

Phrase: "specific fragments of different AC subtypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "(AC I-VI) with the indicated sizes"

Phrase: "(bp"

Phrase: ")"

Phrase: ":"

Phrase: "ACI (444"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0814206:ACI [Intellectual Product]
   861   C2346870:aCi [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5'-CTGCGGGCGTGCGATGAGGA-GTTC"

Phrase: "and"

Phrase: "5'-GCGCACGGGCAGCAGGGCATAG"

Phrase: ";"
Processing 00000000.tx.82: ACII (425), 5'-GCTGGCGTCATAGGGGCTCAAAA and 5'-GGCACGCGCAGACACCAAACAGTA; 

Phrase: "ACII"

Phrase: "(425"

Phrase: ")"

Phrase: ","

Phrase: "5'-GCTGGCGTCATAGGGGCTCAAAA"

Phrase: "and"

Phrase: "5'-GGCACGCGCAGACACCAAACAGTA"

Phrase: ";"
Processing 00000000.tx.83: ACIII (418), 5'-GGACGCCCTTCACCCACAACCAA and 5'-AGACCACCGCGCACATCACTACCA; 

Phrase: "ACIII"

Phrase: "(418"

Phrase: ")"

Phrase: ","

Phrase: "5'-GGACGCCCTTCACCCACAACCAA"

Phrase: "and"

Phrase: "5'-AGACCACCGCGCACATCACTACCA"

Phrase: ";"
Processing 00000000.tx.84: ACIV (454), 5'-CACGGCCGGGATTGCGAGTAGC and 5'-TGCCGAGCCAGGACGAGGAGTGT; 

Phrase: "ACIV"

Phrase: "(454"

Phrase: ")"

Phrase: ","

Phrase: "5'-CACGGCCGGGATTGCGAGTAGC"

Phrase: "and"

Phrase: "5'-TGCCGAGCCAGGACGAGGAGTGT"

Phrase: ";"
Processing 00000000.tx.85: ACV (412), 5'-GAGCCCCAATGACCCCAGCCACTA and 5'-CGGGAGCGGCGCAATGATGAACT; 

Phrase: "ACV (412"

Phrase: ")"

Phrase: ","

Phrase: "5'-GAGCCCCAATGACCCCAGCCACTA"

Phrase: "and"

Phrase: "5'-CGGGAGCGGCGCAATGATGAACT"

Phrase: ";"
Processing 00000000.tx.86: ACVI (362), 5'-CCTGGCGGAAGCTGTGTCGGTTAC and 5'-GCGGTCAGTGGCCTTGGGGTTTG. 

Phrase: "ACVI"

Phrase: "(362"

Phrase: ")"

Phrase: ","

Phrase: "5'-CCTGGCGGAAGCTGTGTCGGTTAC"

Phrase: "and"

Phrase: "5'-GCGGTCAGTGGCCTTGGGGTTTG."
Processing 00000000.tx.87: The PCR reaction was performed with different concentrations of cDNA (0.1,0.5,and 1g/reaction) and repeated at least 2times. 

Phrase: "The PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed with different concentrations of cDNA (0.1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086045:Concentrations [Mental Process]
   744   C0884358:Performed [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "1g/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "repeated at least 2times."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205341:Repeated [Functional Concept]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.88: The amplified DNA fragment was subcloned into pGEM-T Easy vector (Promega) and sequenced by the Sanger dideoxynucleotide chain termination using modified T7 DNA polymerase (Pharmacia Biotech Inc.). 

Phrase: "The amplified DNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "subcloned into pGEM-T Easy vector"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "sequenced by the Sanger dideoxynucleotide chain termination"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0337112:Chain [Manufactured Object]
   748   C0599651:dideoxynucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1524075:Chain [Idea or Concept]
   748   C1549081:Termination [Intellectual Product]
   748   C1692758:termination [Idea or Concept]
   714   C0004793:Sequence [Nucleotide Sequence]
   714   C0162326:Sequence [Nucleotide Sequence]
   714   C0162327:Sequence [Nucleotide Sequence]
   714   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "modified T7 DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.89: cAMP Measurement-- Equivalent numbers of cells were plated in 6-well plates and grown to 70-80% confluence. 

Phrase: "cAMP Measurement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0201979:cAMP measurement [Laboratory Procedure]
   861   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "Equivalent numbers of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "plated in 6-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "grown to 70-80% confluence."
Processing 00000000.tx.90: After rinsing with HBBS buffer (118mM NaCl, 4.6mM KCl, 1.0mM CaCl2, 10mM D-glucose, and 20mM Hepes, pH 7.2) the cells were incubated with or without experimental compounds in 1ml/well of HBBS+100M isobutylmethylxanthine at 37C. 

Phrase: "After"

Phrase: "rinsing with HBBS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882955:Rinsing [Activity]

Phrase: "(118mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "4.6mM KCl,"

Phrase: "1.0mM CaCl2,"

Phrase: "10mM"

Phrase: "D-"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "20mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without experimental compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517586:Experimental [Qualitative Concept]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "in 1ml/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "of HBBS+100M isobutylmethylxanthine"

Phrase: "at 37C."
Processing 00000000.tx.91: After 20min the media were recovered and stored at 20C. 

Phrase: "After 20min"

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.92: Samples were analyzed by specific radioimmunoassay to detect cAMP (34). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by specific radioimmunoassay to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034580:Radioimmunoassay [Laboratory Procedure]
   760   C0205369:Specific [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1552740:specific [Intellectual Product]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "cAMP (34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.93: Percent inhibition was calculated using the following formula: %inhibition=100[100(D-C)/(S-C)], where D=cAMP in dopamine-treated cells; 

Phrase: "Percent inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1628982:Percent inhibition [Quantitative Concept]
           % inhibition
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following formula"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0489829:Formula [Intellectual Product]
   861   C1705501:Formula [Intellectual Product]

Phrase: ":"

Phrase: "%inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "=100"

Phrase: "[100"

Phrase: "(D-C)/(S-C)"

Phrase: "],"

Phrase: "where"

Phrase: "D="

Phrase: "cAMP in dopamine-treated cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.94: C=control or nontreated cells (basal cAMP); 

Phrase: "C=control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "nontreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(basal cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.95: S=stimulated cAMP in forskolin- or PGE1-treated cells. 

Phrase: "S="

Phrase: "stimulated cAMP in forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "or"

Phrase: "PGE1-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.96: Measurement of [Ca2+]i-- Cells were grown to 80% confluence, harvested with trypsin/EDTA, resuspended in 1ml of HBBS with 2M Fura-2 AM and incubated at 37C for 45min with shaking (100rpm). 

Phrase: "Measurement of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i-- Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to 80% confluence,"

Phrase: "harvested with trypsin/EDTA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "resuspended in 1ml of HBBS"

Phrase: "with 2M Fura-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C3171718:2M [Quantitative Concept]

Phrase: "AM"

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 45min"

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "(100rpm"

Phrase: ")."
Processing 00000000.tx.97: The cells were washed twice with HBBS, resuspended in 2ml of HBBS, and subjected to fluorometric measurement. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with HBBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "resuspended in 2ml of HBBS,"

Phrase: "and"

Phrase: "subjected to fluorometric measurement."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0242485:Measurement [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.98: The fluorescence ratio of Fura-2 was monitored in a Perkin-Elmer LS-50 spectrofluorometer at EX=340/380 nm and EM=510nm. 

Phrase: "The fluorescence ratio of Fura-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "monitored in a Perkin-Elmer LS-50 spectrofluorometer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   711   C0030695:monitor [Health Care Activity]
   711   C0150369:monitor [Health Care Activity]
   711   C0181904:Monitor [Medical Device]
   711   C0596972:Monitor [Medical Device]
   711   C1521743:Monitor [Professional or Occupational Group]
   711   C1704646:Monitor [Manufactured Object]

Phrase: "at EX=340/380 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "EM=510nm."
Processing 00000000.tx.99: Calibration was done using 0.1% Triton X-100 and 20mM Tris base to determine Rmax and 10mM EGTA (pH>8) to obtain Rmin (34) and the fluorescence ratio was converted to [Ca2+]i based on a Kd of 227nM for the Fura 2-calcium complex. 

Phrase: "Calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006751:Calibration [Quantitative Concept]

Phrase: "was"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "20mM Tris base to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0041175:Tris-base [Organic Chemical,Pharmacologic Substance]
   812   C0002055:base [Inorganic Chemical]
   812   C0178499:Base [Chemical Viewed Functionally]
   812   C1880279:Base [Biomedical or Dental Material]
   741 E C0205112:Basal [Spatial Concept]
   729 E C0016617:Foundation [Organization]
   729 E C1626935:Bases [Quantitative Concept]

Phrase: "determine"

Phrase: "Rmax"

Phrase: "and"

Phrase: "10mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH>8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Rmin"

Phrase: "(34"

Phrase: ")"

Phrase: "and"

Phrase: "the fluorescence ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "converted"

Phrase: "to [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "based on a Kd of 227nM"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0026691:KD [Disease or Syndrome]
   753   C1527178:Based [Functional Concept]
   753   C1705240:KD [Gene or Genome]
   753   C1705938:Based [Idea or Concept]
   753   C1839259:KD [Disease or Syndrome]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "for the Fura 2-calcium complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.100: Experimental compounds were added directly to cuvette from 100-fold concentrated solutions at the times indicated in the figures. 

Phrase: "Experimental compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "directly to cuvette from 100-fold concentrated solutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0180266:cuvette [Medical Device]

Phrase: "at the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated in the figures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.101: Statistical Analysis-- The data are presented as meanS.E. of at least three independent experiments. 

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as meanS.E. of"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.102: The data were analyzed by repeated measure using ANOVA for each set of experiments. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by repeated measure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079809:Measure [Quantitative Concept]
   770   C0205341:Repeated [Functional Concept]
   770   C0242485:Measure [Functional Concept]
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA for each"

Phrase: "set of experiments."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.103: The percent inhibition data was analyzed with repeated measure using ANOVA and the data from G-PTX expressing clones were compared with LD2S cell (wild type) using Bonferroni multiple comparison post-test.  

Phrase: "The percent inhibition data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C1628982:Percent inhibition [Quantitative Concept]

Phrase: "was"

Phrase: "analyzed with repeated measure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079809:Measure [Quantitative Concept]
   770   C0205341:Repeated [Functional Concept]
   770   C0242485:Measure [Functional Concept]
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"

Phrase: "and"

Phrase: "the data from G-PTX expressing clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "compared with LD2S cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1707455:Compared [Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: "(wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bonferroni multiple comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "post-test."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.104: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Expression of Mutant Gi/o Subtypes in LD2S Cells-- In order to investigate the importance of individual G subtypes in dopamine-mediated responses, PTX-insensitive mutants of Gi/o were generated and stably transfected into LD2S cells (Ltk cells stably transfected with the rat D2S receptor cDNA). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of Mutant Gi/o Subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in LD2S Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the importance of individual G subtypes"

Phrase: "in dopamine-mediated responses,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0870868:mediated responses [Mental Process]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "PTX-insensitive mutants of Gi/o"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "stably"

Phrase: "transfected into LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Ltk cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the rat D2S receptor cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")."
Processing 00000000.tx.105: Transfected clones expressing the highest levels of individual mutant Gi/o RNA were identified by Northern blot analysis (data not shown) and were named RGo, RGi1, RGi2, and RGi3 for clones expressing Go-PTX, Gi1-PTX, Gi2-PTX, and Gi3-PTX, respectively. 

Phrase: "Transfected clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "the highest levels of individual mutant Gi/o RNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "identified by Northern blot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1709269:Northern [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "RGo,"

Phrase: "RGi1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421991:RGI1 [Gene or Genome]

Phrase: "RGi2,"

Phrase: "and"

Phrase: "RGi3 for clones"

Phrase: "expressing"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi1-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi2-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "Gi3-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "respectively."
Processing 00000000.tx.106: Cell extracts from clones of interest were subjected to Western blot analysis to assess at the protein level the overexpression of G proteins (Fig. 1). 

Phrase: "Cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts from clones of interest"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0009013:Clones [Cell]
   760   C0543488:Interest [Mental Process]
   760   C2828366:Extract [Substance]
   726 E C1522642:Clone [Tissue]

Phrase: "were"

Phrase: "subjected to Western blot analysis to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "assess at the protein level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1516048:Assess [Activity]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "the overexpression of G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: Wild-type LD2S cells expressed all four Gi/o subunits, although Go and Gi3 appeared to be the most abundant based on densitometric analysis. 

Phrase: "Wild-type LD2S cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "all four Gi/o subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1711351:Subunit [Quantitative Concept]

Phrase: "although"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "and"

Phrase: "Gi3"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most abundant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]

Phrase: "based on densitometric analysis."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.108: Comparison of Go and Gi3 expression in each transfectant to LD2S (wild type) indicates that transfectant cell lines expressed approximately 2-fold more than the corresponding endogenous G subunit. 

Phrase: "Comparison of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707455:Comparison [Activity]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "and"

Phrase: "Gi3 expression in each transfectant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to LD2S"

Phrase: "(wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "indicates"

Phrase: "that transfectant cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressed"

Phrase: "approximately 2-fold more than the corresponding endogenous G subunit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332462:Fold [Spatial Concept]
   739   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.109: This indicates that approximately equal amounts of mutant and wild-type protein were produced in the transfected cell lines. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that approximately equal amounts of mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "produced in the transfected cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.110: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.111: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.112: Gi/o expression in LD2S cells transfected with PTX-insensitive mutant Gi/o constructs. 

Phrase: "Gi/o expression in LD2S cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "transfected with PTX-insensitive mutant Gi/o constructs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   742   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   742   C0043167:Pertussis [Disease or Syndrome]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C3539617:GI [Idea or Concept]
   708   C2827421:Construct [Classification]
Processing 00000000.tx.113: Cell extracts (100g) of LD2S cells (wt) and LD2S cells expressing: A, Go-PTX (RGo-1, RGo-21); 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "(100g"

Phrase: ")"

Phrase: "of LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "and"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: ":"

Phrase: "A,"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGo-1,"

Phrase: "RGo-21"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.114: B, Gi1-PTX (RGi1-5, RGi1-10); 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gi1-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi1-5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "RGi1-10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.115: C, Gi2-PTX (RGi2-4, RGi2-3); 

Phrase: "C,"

Phrase: "Gi2-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi2-4,"

Phrase: "RGi2-3"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.116: and D, Gi3-PTX (RGi3-2) were subjected to Western blot analysis as described under "Experimental Procedures." 

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gi3-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi3-2"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.117: The blots were probed with: A, anti-Go; 

Phrase: "The blots"

Phrase: "were"

Phrase: "probed with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: ":"

Phrase: "A,"

Phrase: "anti-"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.118: B and C, anti-Gi1-2; 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "anti-Gi1-2"

Phrase: ";"
Processing 00000000.tx.119: and D, anti-Gi3 antibodies. 

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "anti-Gi3 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.120: Gi2-PTX Mediates D2S-induced Inhibition of Forskolin-stimulated cAMP Accumulation-- In LD2S cells, dopamine did not alter the basal cAMP production (21). 

Phrase: "Gi2-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "D2S-induced Inhibition of Forskolin-stimulated cAMP Accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "-"

Phrase: "-"

Phrase: "In LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the basal cAMP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.121: Upon addition of forskolin (10M), cAMP levels were increased by 4.5-fold compared with basal (2.220.17versus 0.500.04pmol/ml) (Fig. 2A). 

Phrase: "Upon addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "cAMP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased by 4.5-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205112:Basal [Spatial Concept]
   790   C1707455:Compared [Activity]

Phrase: "(2.220.17versus 0.500.04pmol/ml) (Fig. 2A"

Phrase: ")."
Processing 00000000.tx.122: Dopamine (10M) inhibited forskolin-stimulated cAMP accumulation in these cells by 84.512.2% (n=5), an action that was mimicked by apomorphine (1M, not shown) and was largely reversed by pretreatment with PTX (Fig. 2A), indicating the involvement of Gi/o proteins. 

Phrase: "Dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "forskolin-stimulated cAMP accumulation in these cells"

Phrase: "by 84.512.2%"

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "an action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "that"

Phrase: "was"

Phrase: "mimicked by apomorphine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003596:Apomorphine [Organic Chemical,Pharmacologic Substance]

Phrase: "(1M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "largely"

Phrase: "reversed by pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "with PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the involvement of Gi/o proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.123: PGE1 has been shown to induce a concentration-dependent increase in cAMP production indicating the presence of endogenous Gs-coupled PGE1 receptors (30). 

Phrase: "PGE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a concentration-dependent increase in cAMP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "indicating"

Phrase: "the presence of endogenous Gs-coupled PGE1 receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.124: In LD2S cells, PGE1 (1M) increased cAMP accumulation by 7-8-fold basal cAMP (1.650.25versus 0.1960.002pmol/ml) (Fig. 2B). 

Phrase: "In LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "PGE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "increased cAMP accumulation"

Phrase: "by 7-8-fold basal cAMP (1.650.25versus 0.1960.002pmol/ml) (Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C0450354:2b [Intellectual Product]
   786   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.125: The greater effect of PGE1 may be related to the specific isoforms of adenylyl cyclase present in LD2S cells. 

Phrase: "The greater effect of PGE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to the specific isoforms of adenylyl cyclase present"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0150312:Present [Quantitative Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0449450:Present [Idea or Concept]
   742   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   742   C1552740:specific [Intellectual Product]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: Activation of D2S receptors with apomorphine (1M) inhibited PGE1-induced cAMP production by 66.37.3% (Fig. 2B) and this action of apomorphine was largely reversed after PTX treatment, implicating Gi/o proteins. 

Phrase: "Activation of D2S receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1514758:Receptor Activation [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "with apomorphine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003596:Apomorphine [Organic Chemical,Pharmacologic Substance]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PGE1-induced cAMP production by 66.37.3%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "this action of apomorphine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "was"

Phrase: "largely"

Phrase: "reversed after PTX treatment,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "implicating"

Phrase: "Gi/o proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.127: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.129: PTX-sensitive inhibition of forskolin and PGE1-induced cAMP accumulation in LD2S cells. 

Phrase: "PTX-sensitive inhibition of forskolin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "PGE1-induced cAMP accumulation in LD2S cells."
Processing 00000000.tx.130: A, inhibition of forskolin action. 

Phrase: "A,"

Phrase: "inhibition of forskolin action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.131: B, inhibition of PGE1 action. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "inhibition of PGE1 action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.132: Cells were treated with or without PTX (50ng/ml, 16h) and incubated for 20min with: A, no drugs (Control), forskolin (10M), dopamine (10M) or both; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(50ng/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "16h"

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 20min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with"

Phrase: ":"

Phrase: "A,"

Phrase: "no drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "both"

Phrase: ";"
Processing 00000000.tx.133: or B, no drugs (Control), PGE1 (1M), apomorphine (10M, Apo), or both. 

Phrase: "or"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "no drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "PGE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "apomorphine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003596:Apomorphine [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "Apo"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.134: The level of cAMP was measured as described under "Experimental Procedures." 

Phrase: "The level of cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.135: The data are expressed as meanS.E. of triplicate determinations. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.E. of triplicate determinations."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0680730:determinations [Governmental or Regulatory Activity]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C1148554:determination [Laboratory Procedure]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.136: The PTX sensitivity of dopamine-mediated inhibition of forskolin-induced cAMP production was examined in wild-type LD2S and stable clones expressing the mutant G subunits. 

Phrase: "The PTX sensitivity of dopamine-mediated inhibition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   744   C0043167:Pertussis [Disease or Syndrome]
   744   C0312418:Sensitivity [Mental Process]
   744   C0427965:Sensitivity [Finding]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]

Phrase: "of forskolin-induced cAMP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "examined in wild-type LD2S"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332128:Examined [Finding]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "stable clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "the mutant G subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.137: Dopamine inhibited forskolin-stimulated cAMP accumulation in all clones expressing mutant Gi/o proteins, as observed in LD2S cells (wild type). 

Phrase: "Dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "forskolin-stimulated cAMP accumulation in all"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "expressing"

Phrase: "mutant Gi/o proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "observed in LD2S cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: However, PTX blocked dopamine action in all clones except for those clones which express the mutant Gi2-PTX. 

Phrase: "However,"

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "dopamine action in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "clones except for those clones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0009013:Clones [Cell]
   726 E C1522642:Clone [Tissue]

Phrase: "which"

Phrase: "express"

Phrase: "the mutant Gi2-PTX."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   812   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   812   C0043167:Pertussis [Disease or Syndrome]
Processing 00000000.tx.139: In multiple experiments, the percent inhibition by dopamine of forskolin-stimulated cAMP accumulation was unaltered by PTX in only RGi2-3 and RGi2-4 clones, whereas in other clones a significant attenuation of dopamine action by PTX was observed (Fig. 3). 

Phrase: "In multiple experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the percent inhibition by dopamine of forskolin-stimulated cAMP accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1628982:Percent inhibition [Quantitative Concept]
           % inhibition
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "unaltered by PTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709843:Unaltered [Qualitative Concept]

Phrase: "in only RGi2-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "RGi2-4 clones,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "whereas in other"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "a significant attenuation of dopamine action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599946:Attenuation [Activity]

Phrase: "by PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.140: These results indicate that the PTX-insensitive mutant of Gi2 is functional and that Gi2 is the only subunit required for D2S-mediated inhibition of forskolin-induced cAMP production in LD2S cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the PTX-insensitive mutant of Gi2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "that Gi2"

Phrase: "is"

Phrase: "the only subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "required for D2S-mediated inhibition of forskolin-induced cAMP production"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0033268:production [Occupational Activity]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0205263:Induced [Functional Concept]
   739   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   739   C1514873:Required [Functional Concept]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.141: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.143: PTX-resistant inhibition of forskolin-induced cAMP accumulation in LD2S cells expressing the Gi2 mutant. 

Phrase: "PTX-resistant inhibition of forskolin-induced cAMP accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Gi2 mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.144: Dopamine D2S receptor-induced inhibition of cAMP accumulation in LD2S cells expressing PTX-insensitive Gi/o mutants was calculated as: %inhibition=100[100(D-C)/(S-C)], where D=cAMP level in dopamine/forskolin-treated cells; 

Phrase: "Dopamine D2S receptor-induced inhibition of cAMP accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514761:Receptor Inhibition [Cell Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PTX-insensitive Gi/o mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: ":"

Phrase: "%inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "=100"

Phrase: "[100"

Phrase: "(D-C)/(S-C)"

Phrase: "],"

Phrase: "where"

Phrase: "D="

Phrase: "cAMP level in dopamine/forskolin-treated cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.145: C, cAMP level in control, nontreated cells; 

Phrase: "C,"

Phrase: "cAMP level in control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "nontreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.146: S, cAMP level in cells stimulated by forskolin. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "cAMP level in cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "stimulated by forskolin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.147: Percent inhibition of dopamine action with or without PTX treatment from four independent experiments (n=4) are summarized. 

Phrase: "Percent inhibition of dopamine action"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1628982:Percent inhibition [Quantitative Concept]
           % inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C3463820:Inhibition [Activity]

Phrase: "with"

Phrase: "or without PTX treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "from four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "summarized."
Processing 00000000.tx.148: The data are expressed as meanS.E., and were analyzed by repeated measures using ANOVA with Bonferroni multiple comparison. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.E.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed by repeated measures"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0871881:repeated measures [Research Activity]
   770   C0079809:Measures [Quantitative Concept]
   770   C0205341:Repeated [Functional Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C1879489:Measures [Functional Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA with Bonferroni multiple comparison."
Processing 00000000.tx.149: In all clones, basal and forskolin-induced cAMP levels were not significantly different from levels in non-transfected LD2S cells. 

Phrase: "In all clones,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "forskolin-induced cAMP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not significantly different from levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "in non-transfected LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.150: LD2S cells, parent cell line; 

Phrase: "LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "parent cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.151: RGo-1, LD2S cells expressing Go-PTX; 

Phrase: "RGo-1,"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.152: RGi1-5 and RGi1-10, expressing Gi1-PTX; 

Phrase: "RGi1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "and"

Phrase: "RGi1-10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "expressing"

Phrase: "Gi1-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.153: RGi2-3 and RGi2-4, expressing Gi2-PTX; 

Phrase: "RGi2-3"

Phrase: "and"

Phrase: "RGi2-4,"

Phrase: "expressing"

Phrase: "Gi2-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.154: RGi3-2, expressing Gi3-PTX. 

Phrase: "RGi3-2,"

Phrase: "expressing"

Phrase: "Gi3-PTX."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]
Processing 00000000.tx.155: Gi3-PTX Mediates D2S Inhibition of PGE1-stimulated cAMP Production-- The ability of D2S receptor activation to inhibit Gs-coupled stimulation of cAMP accumulation was tested in the LD2S clones expressing PTX-insensitive G proteins. 

Phrase: "Gi3-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "D2S Inhibition of PGE1-stimulated cAMP Production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "-"

Phrase: "-"

Phrase: "The ability of D2S receptor activation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Gs-coupled stimulation of cAMP accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "tested in the LD2S clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0009013:Clones [Cell]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "expressing"

Phrase: "PTX-insensitive G proteins."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   840   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   804   C0043167:Pertussis [Disease or Syndrome]
   804   C0439267:g% [Quantitative Concept]
   733   C0237677:Insensitivity [Finding]
Processing 00000000.tx.156: In these clones PGE1 (1M) induced a 7-8-fold increase in basal cAMP and apomorphine inhibited PGE1-stimulated cAMP production by 60-70%, comparable to wild-type LD2S cells. 

Phrase: "In these clones PGE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
   861   C3538799:PGE1 [Laboratory Procedure]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 7-8-fold increase in basal cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "apomorphine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003596:Apomorphine [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PGE1-stimulated cAMP production by 60-70%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "comparable to wild-type LD2S cells."
Processing 00000000.tx.157: Upon pretreatment with PTX, apomorphine-mediated inhibition was completely reversed in RGo, RGi1, and RGi2 clones. 

Phrase: "Upon pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "apomorphine-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "reversed in RGo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1555029:Reverse [Idea or Concept]

Phrase: "RGi1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421991:RGI1 [Gene or Genome]

Phrase: "and"

Phrase: "RGi2 clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.158: In contrast, PTX treatment of the RGi3-2 clone did not block apomorphine-mediated inhibition of the PGE1 response. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "PTX treatment of the RGi3-2 clone"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "apomorphine-mediated inhibition of the PGE1 response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1510574:Response Inhibition [Mental Process]
   774   C3463820:Response Inhibition [Activity]
           Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
Processing 00000000.tx.159: In multiple experiments, clone RGi3-2 retained significantly higher dopamine inhibitory activity following PTX treatment than any of the other clones (Fig. 4). 

Phrase: "In multiple experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "clone RGi3-2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "significantly higher dopamine inhibitory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "PTX treatment than any of the"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "other clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: Thus, the inhibitory action of the D2S receptor on Gs-coupled enhancement of cAMP is mediated through the Gi3 subunit, rather than the Gi2 subunit as observed for forskolin-induced cAMP accumulation. 

Phrase: "Thus,"

Phrase: "the inhibitory action of the D2S receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "on Gs-coupled enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   827   C2349975:Enhancement [Activity]

Phrase: "of cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "is"

Phrase: "mediated through the Gi3 subunit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1711351:Subunit [Quantitative Concept]

Phrase: "rather than"

Phrase: "the Gi2 subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "as"

Phrase: "observed for forskolin-induced cAMP accumulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.161: These results show that the D2S receptor utilizes distinct Gi subtypes to inhibit forskolin- or Gs-stimulated adenylyl cyclase activity. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "utilizes"

Phrase: "distinct Gi subtypes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449560:subtypes [Classification]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Gs-stimulated adenylyl cyclase activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1151015:adenylyl cyclase activity [Molecular Function]
   840   C1323396:cyclase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.162: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 4.  

Phrase: "4."
Processing 00000000.tx.164: PTX-resistant inhibition of PGE1-induced cAMP accumulation in LD2S cells expressing the Gi3 mutant. 

Phrase: "PTX-resistant inhibition of PGE1-induced cAMP accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Gi3 mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.165: Dopamine D2S receptor-induced inhibition of cAMP accumulation in LD2S cells expressing PTX-insensitive Gi/o mutants was calculated as: %inhibition=100[100(D-C)/(S-C)], where D, cAMP level in apomorphine/PGE1-treated cells; 

Phrase: "Dopamine D2S receptor-induced inhibition of cAMP accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514761:Receptor Inhibition [Cell Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PTX-insensitive Gi/o mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: ":"

Phrase: "%inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "=100"

Phrase: "[100"

Phrase: "(D-C)/(S-C)"

Phrase: "],"

Phrase: "where D,"

Phrase: "cAMP level in apomorphine/PGE1-treated cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.166: C, cAMP level in control, nontreated cells; 

Phrase: "C,"

Phrase: "cAMP level in control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "nontreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.167: S, cAMP level in cells stimulated by PGE1. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "cAMP level in cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "stimulated by PGE1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   790   C3538799:PGE1 [Laboratory Procedure]
Processing 00000000.tx.168: Percent inhibition of apomorphine effect with or without PTX treatment from four independent experiments (n=4) is summarized. 

Phrase: "Percent inhibition of apomorphine effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1628982:Percent inhibition [Quantitative Concept]
           % inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C3463820:Inhibition [Activity]

Phrase: "with"

Phrase: "or without PTX treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "from four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "summarized."
Processing 00000000.tx.169: The data are expressed as meanS.E., and were analyzed by repeated measures using ANOVA with Bonferroni multiple comparison. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.E.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed by repeated measures"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0871881:repeated measures [Research Activity]
   770   C0079809:Measures [Quantitative Concept]
   770   C0205341:Repeated [Functional Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C1879489:Measures [Functional Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA with Bonferroni multiple comparison."
Processing 00000000.tx.170: LD2S cells, parent cell line; 

Phrase: "LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "parent cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.171: RGo-1 and RGo-21, LD2S cells expressing Go-PTX; 

Phrase: "RGo-1"

Phrase: "and"

Phrase: "RGo-21,"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.172: RGi1-5 and RGi1-10, expressing Gi1-PTX; 

Phrase: "RGi1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "and"

Phrase: "RGi1-10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "expressing"

Phrase: "Gi1-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.173: RGi2-3 and RGi2-4, expressing Gi2-PTX; 

Phrase: "RGi2-3"

Phrase: "and"

Phrase: "RGi2-4,"

Phrase: "expressing"

Phrase: "Gi2-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.174: RGi3-2, expressing Gi3-PTX. 

Phrase: "RGi3-2,"

Phrase: "expressing"

Phrase: "Gi3-PTX."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]
Processing 00000000.tx.175: In these clones, the PGE1-induced cAMP level was not significantly different from non-transfected LD2S cells. 

Phrase: "In these clones,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "the PGE1-induced cAMP level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not significantly different from non-transfected LD2S cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.176: Adenylyl Cyclase Expression in LD2S Cells-- To further investigate the role of AC expression in LD2S cells, we performed semi-quantitative reverse transcriptase-PCR to determine the relative expression of AC subtypes I-VI, since their regulation has been well characterized compare with other subtypes (VII-X) (21, 35-37). 

Phrase: "Adenylyl Cyclase Expression in LD2S Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of AC expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "semi-quantitative reverse transcriptase-PCR to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1514628:Quantitative Reverse Transcriptase PCR [Molecular Biology Research Technique]
   861   C0599161:Reverse Transcriptase PCR [Molecular Biology Research Technique]
   799   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0677874:pCR [Finding]

Phrase: "determine"

Phrase: "the relative expression of AC subtypes I-VI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "since"

Phrase: "their regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "well characterized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1880022:Characterized [Activity]
   861   C3146287:Well [Manufactured Object]

Phrase: "compare with other subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449560:subtypes [Classification]
   770   C1707455:Compare [Activity]

Phrase: "(VII-X) (21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0445385:VII [Intellectual Product]

Phrase: "35-37"

Phrase: ")."
Processing 00000000.tx.177: The PCR was performed with different concentrations of cDNA (0.1,0.5,and 1.0g/reaction) and repeated at least twice for each concentration. 

Phrase: "The PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with different concentrations of cDNA (0.1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086045:Concentrations [Mental Process]
   744   C0884358:Performed [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "1.0g/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "repeated at least twice"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205341:Repeated [Functional Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1705914:Repeat [Conceptual Entity]

Phrase: "for each concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.178: Each PCR reaction amplified a single, specific product with the predicted sized for each AC subtypes, and the sequence was confirmed by sequencing the subcloned fragment. 

Phrase: "Each PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "amplified"

Phrase: "a single, specific product with the predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "sized for each AC subtypes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449560:subtypes [Classification]
   760   C1412573:AC [Gene or Genome]
   760   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3539770:AC [Gene or Genome]
   726   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "the subcloned fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.179: The specificity of the primers used was not altered with change in cDNA concentration, but the intensity of the product increased with concentration (Table I). 

Phrase: "The specificity of the primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered with change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0392747:Altered [Functional Concept]
           Change
   790   C0443172:change [Quantitative Concept]
   790   C1705241:Change [Quantitative Concept]

Phrase: "in cDNA concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "but"

Phrase: "the intensity of the product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "increased with concentration"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0086045:Concentration [Mental Process]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1446561:Concentration [Quantitative Concept]
   718 E C1517378:Gain [Quantitative Concept]
   718 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.180: Mouse brain RNA was used as positive control and was found to express all the subtypes of AC (data not shown). 

Phrase: "Mouse brain RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1521713:Mouse Brain [Tissue]

Phrase: "was"

Phrase: "used as positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "all the subtypes of AC (data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449560:subtypes [Classification]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: In LD2S cells, RNA for AC I and VI was expressed more abundantly than AC III, AC IV, and AC II (ACI=ACVI>ACIII>ACIV>ACII) and AC V RNA was not detected in these cells (Table I). 

Phrase: "In LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "RNA for AC I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0073424:RNA I [Nucleic Acid, Nucleoside, or Nucleotide]
   819   C0073433:I-RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "VI"

Phrase: "was"

Phrase: "expressed"

Phrase: "more abundantly than AC III,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205172:More [Functional Concept]
   760   C0439070:III [Intellectual Product]
   760   C1412573:AC [Gene or Genome]
   760   C1705160:III [Qualitative Concept]
   760   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3539770:AC [Gene or Genome]

Phrase: "AC IV,"

Phrase: "and"

Phrase: "AC II"

Phrase: "(ACI=ACVI"

Phrase: ">ACIII"

Phrase: ">ACIV"

Phrase: ">ACII"

Phrase: ")"

Phrase: "and"

Phrase: "AC V RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in these cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.182: These results indicate that LD2S cells express AC subtypes at different levels, which may direct the specificity of signaling through AC in these cells.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "AC subtypes at different levels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:subtypes [Classification]

Phrase: "which"

Phrase: "may"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "the specificity of signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "through AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.183: View this table: [in this window] [in a new window]  Table I Expression of different adenylyl cyclase subtypes in LD2S cells Gi/o Protein Subtypes Involved in Calcium Mobilization in LD2S Cells-- In LD2S cells, the D2S receptor couples to PI turnover to induce mobilization of calcium from ionomycin-sensitive intracellular stores (8). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Expression of different adenylyl cyclase subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in LD2S cells Gi/o Protein Subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0449560:subtypes [Classification]

Phrase: "Involved in Calcium Mobilization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0596233:calcium mobilization [Cell Function]
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   770   C0300926:mobilization [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C2936886:Calcium [Pharmacologic Substance]

Phrase: "in LD2S Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "couples to PI turnover to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0010222:Couples [Family Group]
   760   C0031227:turnover [Quantitative Concept]
   760   C0243127:turnover [Functional Concept]
   760   C0429863:PI [Clinical Attribute]
   760   C0443331:Turnover [Health Care Activity]
   760   C1948027:Couple [Functional Concept]
   760   C3537219:PI [Gene or Genome]
   760   C3539772:PI [Intellectual Product]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mobilization of calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0596233:calcium mobilization [Cell Function]
   790   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   790   C0300926:mobilization [Functional Concept]

Phrase: "from ionomycin-sensitive intracellular stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1698986:Store [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.184: In LD2S cells dopamine induced a 2-2.5-fold increase in [Ca2+]i (Fig. 5) which was blocked by the D2 receptor antagonist spiperone and was not observed in D2 receptor-negative Ltk cells (data not shown), indicating that this effect is mediated by the D2S receptor. 

Phrase: "In LD2S cells dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 2-2.5-fold increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i (Fig. 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")"

Phrase: "which"

Phrase: "was"

Phrase: "blocked by the D2 receptor antagonist spiperone"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   814   C2917388:D2 Receptor Antagonist [Pharmacologic Substance]
   778   C0058698:D2 receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0075021:spiperone receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0028778:Blocked [Pathologic Function]
   748   C0037956:Spiperone [Organic Chemical,Pharmacologic Substance]
   748   C0231491:Antagonist [Organ or Tissue Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1414052:D2 [Gene or Genome]
   748   C1415944:D2 [Gene or Genome]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in D2 receptor-negative Ltk cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0058698:D2 receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C1514760:Receptor Cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0205160:Negative [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1414052:D2 [Gene or Genome]
   748   C1415944:D2 [Gene or Genome]
   748   C1441672:Observed [Functional Concept]
   748   C1513916:Negative [Finding]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by the D2S receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.185: The increase in [Ca2+]i induced by dopamine was completely inhibited by PTX pretreatment, suggesting mediation via Gi/o proteins. 

Phrase: "The increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induced by dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited by PTX pretreatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "mediation via Gi/o proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680727:Mediation [Social Behavior]
Processing 00000000.tx.186: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.188: PTX blocks D2S-induced calcium mobilization in LD2S cells expressing PTX-insensitive single Gi/o-PTX mutants. 

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "D2S-induced calcium mobilization in LD2S cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0596233:calcium mobilization [Cell Function]
   748   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   748   C0300926:mobilization [Functional Concept]

Phrase: "expressing"

Phrase: "PTX-insensitive single Gi/o-PTX mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.189: Ltk cells expressing D2S receptor (LD2S, A) and LD2S cells expressing Go-PTX (RGo-1, B), Gi1-PTX (RGi1-10, C), Gi2-PTX (RGi2-4, D), and Gi3-PTX (RGi3-2, E) mutant G proteins were treated without (solid line) or with (dash line) PTX (50ng/ml, 16h) and changes in intracellular [Ca2+]i in response to dopamine (10M) or ATP (10M) were measured. 

Phrase: "Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(LD2S,"

Phrase: "A)"

Phrase: "and"

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGo-1,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Gi1-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi1-10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421991:RGI1 [Gene or Genome]

Phrase: "C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gi2-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi2-4,"

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: "Gi3-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(RGi3-2,"

Phrase: "E) mutant G proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   886   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   861   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "treated without"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332293:treated [Therapeutic or Preventive Procedure]
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "(solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "or with"

Phrase: "(dash line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(50ng/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "16h"

Phrase: ")"

Phrase: "and"

Phrase: "changes in intracellular"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0175996:intracellular [Cell Component]
   790   C0178719:Intracellular [Spatial Concept]
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1705241:Change [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021966:I- [Inorganic Chemical]
   790   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "ATP"

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.190: Each of the clones expressing mutant G proteins responded to dopamine with a 2-2.5-fold increase in [Ca2+]i (Fig. 6). 

Phrase: "Each of the clones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0009013:Clones [Cell]
   770   C1457900:Each [Quantitative Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "expressing"

Phrase: "mutant G proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "responded to dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "with a 2-2.5-fold increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i (Fig. 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1515148:I 6 [Cell]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.191: Following pretreatment with PTX, none of the mutant G protein transfectants exhibited a D2S-mediated calcium response (Fig. 6). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "pretreatment with PTX,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "none of the mutant G protein transfectants"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C0456148:None [Quantitative Concept]
   748   C0549184:None [Quantitative Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a D2S-mediated calcium response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0870868:mediated response [Mental Process]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.192: In order to test whether more than one G protein could rescue the calcium response, Ltk cells were transfected with different pairs of the four G-PTX mutant constructs along with D2S receptor and assayed for [Ca2+]i. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "more than one G protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   797 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205172:More [Functional Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0439267:g% [Quantitative Concept]

Phrase: "could"

Phrase: "rescue"

Phrase: "the calcium response,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with different pairs of the four G-PTX mutant constructs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   736   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   736   C0043167:Pertussis [Disease or Syndrome]
   736   C0205450:Four [Quantitative Concept]
   736   C0439267:g% [Quantitative Concept]
   736   C0596988:Mutant [Cell or Molecular Dysfunction]
   736   C1705242:Different [Qualitative Concept]
   736   C1709450:Pair [Qualitative Concept]
   703   C2827421:Construct [Classification]

Phrase: "along with D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "assayed for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.193: In all sets dopamine increased [Ca2+]i by 1.6-fold (Fig. 6), similar to that in LD2S cells (33). 

Phrase: "In all"

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i by 1.6-fold"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   797   C1425233:I-1 [Gene or Genome]
   797   C1515148:I 6 [Cell]
   797   C3540559:I-1 [Gene or Genome]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.194: This indicates that the Ltk cells express sufficient levels of transiently transfected cDNAs to mediate a full functional response. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "sufficient levels of transiently transfected cDNAs to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "a full functional response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.195: However, after PTX treatment, none of the mutant combinations rescued the dopamine response (Fig. 6). 

Phrase: "However,"

Phrase: "after"

Phrase: "PTX treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "none of the mutant combinations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0453882:Combinations [Manufactured Object]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "rescued"

Phrase: "the dopamine response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.196: In these experiments, the increase of [Ca2+]i induced by 100M ATP served as a positive control for cellular responsiveness and was unchanged following PTX pretreatment, since the ATP response is mediated through a Gq-coupled P2-purinergic receptor. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the increase of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induced by 100M ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205263:Induced [Functional Concept]

Phrase: "served as a positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "for cellular responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]

Phrase: "and"

Phrase: "was"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "PTX pretreatment,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "since"

Phrase: "the ATP response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "mediated through a Gq-coupled P2-purinergic receptor."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   789   C0206495:Receptor, Purinergic P2 [Amino Acid, Peptide, or Protein,Receptor]
   770   C0034836:Purinergic receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C1152840:P2 receptor [Molecular Function]
   744   C0014651:GQ [Geographic Area]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1384585:P2 [Immunologic Factor]
   744   C1419693:P2 [Gene or Genome]
   744   C1539372:p2 [Gene or Genome]
   744   C1948027:Coupled [Functional Concept]
   711 E C0010222:couple [Family Group]
Processing 00000000.tx.197: Similarly, in LD2S cells transiently transfected with pairs of G-PTX plasmids, PTX pretreatment blocked completely the dopamine-mediated calcium responses for all combinations (data not shown). 

Phrase: "Similarly,"

Phrase: "in LD2S cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pairs of G-PTX plasmids,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   744   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   744   C0043167:Pertussis [Disease or Syndrome]
   744   C0439267:g% [Quantitative Concept]
   744   C1709450:Pair [Qualitative Concept]

Phrase: "PTX pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "the dopamine-mediated calcium responses for all combinations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0870868:mediated responses [Mental Process]
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: The dopamine response was also tested in another series of transfections in which a double dose (60g) of single G-PTX plasmid was transiently transfected in LD2S cells. 

Phrase: "The dopamine response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "also"

Phrase: "tested in another series of transfections"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
   753   C0205549:Series [Quantitative Concept]
   753   C0392366:tested [Intellectual Product]
   753   C2348044:Series [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "in which"

Phrase: "a double dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]

Phrase: "(60g"

Phrase: ")"

Phrase: "of single G-PTX plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transiently"

Phrase: "transfected in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.199: As for the stable LD2S clones (see above), the single G-PTX did not mediate the D2S calcium response in these transfections (data not shown). 

Phrase: "As for the stable LD2S clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the single G-PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   812   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   812   C0043167:Pertussis [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the D2S calcium response in these transfections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: The protein level of the Gi1 and Gi2 was increased by more than 2-fold in Ltk cells transiently transfected by both of these proteins (Fig. 6, inset). 

Phrase: "The protein level of the Gi1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "Gi2"

Phrase: "was"

Phrase: "increased by more"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "than 2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in Ltk cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected by both of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.201: Based on these results, none of the Gi/o subunits, alone or in combination, mediated calcium mobilization induced by dopamine in LD2S cells. 

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "none of the Gi/o subunits,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C3539617:GI [Idea or Concept]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "mediated calcium mobilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596233:calcium mobilization [Cell Function]
   827   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   827   C0300926:mobilization [Functional Concept]

Phrase: "induced by dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 6.  

Phrase: "6."
Processing 00000000.tx.204: Calcium mobilization in LD2S cells expressing pairs of Gi/o-PTX mutants. 

Phrase: "Calcium mobilization in LD2S cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596233:calcium mobilization [Cell Function]
   760   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   760   C0300926:mobilization [Functional Concept]

Phrase: "expressing"

Phrase: "pairs of Gi/o-PTX mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.205: Ltk cells were transiently co-transfected with pairs of Gi/o-PTX mutant proteins and D2S receptor. 

Phrase: "Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "co-transfected with pairs of Gi/o-PTX mutant proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   756   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   738   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   738   C0043167:Pertussis [Disease or Syndrome]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C1709450:Pair [Qualitative Concept]
   738   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "D2S receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.206: The arrows indicate addition of 10M dopamine and 10M ATP to cells pretreated with PTX (50ng/ml, 16h). 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "addition of 10M dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "10M ATP to cells"

Phrase: "pretreated with PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(50ng/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "16h"

Phrase: ")."
Processing 00000000.tx.207: Cells were transfected with: A, Go-PTX/Gi1-PTX, Go-PTX/Gi2-PTX, or Go-PTX/Gi3-PTX; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with"

Phrase: ":"

Phrase: "A,"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX/Gi1-PTX,"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX/Gi2-PTX,"

Phrase: "or"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "PTX/Gi3-PTX"

Phrase: ";"
Processing 00000000.tx.208: B, Gi1-PTX/Gi2-PTX, Gi1-PTX/Gi3-PTX, or Gi1-PTX/Gi3-PTX. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gi1-PTX/Gi2-PTX,"

Phrase: "Gi1-PTX/Gi3-PTX,"

Phrase: "or"

Phrase: "Gi1-PTX/Gi3-PTX."
Processing 00000000.tx.209: Inset, Western blot an- alysis of Gi1-2 protein expression. 

Phrase: "Inset,"

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "an- alysis of Gi1-2 protein expression."
Processing 00000000.tx.210: Ltk cells were transiently transfected with Gi1-PTX, Gi2-PTX, or Gi1-PTX/Gi2-PTX. 

Phrase: "Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with Gi1-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]

Phrase: "Gi2-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "or"

Phrase: "Gi1-PTX/Gi2-PTX."
Processing 00000000.tx.211: Cell extracts (200g/lane) from non-transfected (Ltk) and transfected cells were subjected to SDS-polyacrylamide gel electrophoresis and the Gi1-2 protein was detected using Gi1-2 antibody. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "(200g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "from non-transfected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "(Ltk)"

Phrase: "and"

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the Gi1-2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gi1-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.212: G Subunits Mediate D2S-induced Calcium Mobilization in LD2S Cells-- In order to investigate the role of G subunit of Gi/Go proteins in D2S-mediated increase in [Ca2+]i, LD2S cells were stably transfected with the His6-tagged carboxyl-terminal of GRK-2 (GRK-CT), which contains a pleckstrin homology domain that is known to bind and inactivate free G subunits (38). 

Phrase: "G Subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "Mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "D2S-induced Calcium Mobilization in LD2S Cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0596233:calcium mobilization [Cell Function]
   748   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   748   C0300926:mobilization [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of G subunit of Gi/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "proteins in D2S-mediated increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with the His6-tagged carboxyl-terminal of GRK-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   743   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0205088:Terminal [Temporal Concept]
   739   C0596260:Carboxyl [Organic Chemical]
   739   C0872383:GRK [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708632:Tagged [Qualitative Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "(GRK-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a pleckstrin homology domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1518792:Pleckstrin-Homology Domain [Amino Acid Sequence]
   827   C0071246:pleckstrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1334043:Homology [Gene or Genome]
   827   C1418644:PLECKSTRIN [Gene or Genome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C2697616:Homology [Qualitative Concept]
   827   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "inactivate"

Phrase: "free G subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.213: The relative level of His-GRK-CT protein in clones expressing His-GRK-CT was determined by Western blot using an antibody against the His epitope (Fig. 7, inset). 

Phrase: "The relative level of His-GRK-CT protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "His-GRK-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "was"

Phrase: "determined by Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody against the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "His epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.214: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.215: 7, the dopamine-induced increase in [Ca2+]i was reduced by 80% compared with LD2S cells in the clone expressing His-GRK-CT (RD-21). 

Phrase: "7,"

Phrase: "the dopamine-induced increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "reduced by 80%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with LD2S cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "His-GRK-CT (RD-21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0872383:GRK [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.216: In contrast, dopamine mediated inhibition of forskolin- and PGE1-stimulated cAMP accumulation was not significantly different between LD2S and RD-21 cells (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibition of forskolin-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "PGE1-stimulated cAMP accumulation"

Phrase: "was"

Phrase: "not significantly different between LD2S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "RD-21 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: In another clone expressing lower levels (20%) of His-GRK-CT than RD-21, the increase in [Ca2+]i induced by dopamine was reduced by only 30% (data not shown). 

Phrase: "In another clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "lower levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(20%"

Phrase: ")"

Phrase: "of His-GRK-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "than RD-21,"

Phrase: "the increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induced by dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "reduced by only 30%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.218: These results suggest that D2S-mediated stimulation of [Ca2+]i is mediated by G subunits and is more dependent on G subunits than particular G subunits. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that D2S-mediated stimulation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "mediated by G subunits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0439267:g% [Quantitative Concept]
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "more dependent on G subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "than particular G subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.219: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.220: 7.  

Phrase: "7."
Processing 00000000.tx.221: Inhibition of calcium mobilization in LD2S cells expressing His-GRK-CT protein. 

Phrase: "Inhibition of calcium mobilization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "His-GRK-CT protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.222: Change in [Ca2+]i was measured in LD2S cells (wt) and LD2S cells stably transfected with His-GRK-CT protein (RD-21). 

Phrase: "Change in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "measured in LD2S cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "and"

Phrase: "LD2S cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with His-GRK-CT protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0872383:GRK [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1412323:HIS [Gene or Genome]
   753   C3540513:CT [Gene or Genome]

Phrase: "(RD-21"

Phrase: ")."
Processing 00000000.tx.223: The arrows indicate the addition of dopamine (10M) or ATP (10M). 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the addition of dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "ATP"

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.224: Inset, Western blot analysis of LD2S and RD-21 cells. 

Phrase: "Inset,"

Phrase: "Western blot analysis of LD2S"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "RD-21 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.225: Cell extracts (100g/lane) from LD2S and RD-21 cells were subjected to SDS-polyacrylamide gel electrophoresis and recombinent protein were detected using an anti-RGS-His6 antibody. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "(100g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "from LD2S"

Phrase: "and"

Phrase: "RD-21 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "recombinent protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-RGS-His6 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.226: The arrow indicates the 24-kDa recombinant His-GRK-CT protein.  

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the 24-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "His-GRK-CT protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.227: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES State-dependent Modulation of Adenylyl Cyclase via Distinct G Proteins-- The dopamine-D2S receptor is coupled to inhibition of adenylyl cyclase in a wide variety of cell types (13, 14, 39-41). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "State-dependent Modulation of Adenylyl Cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "via Distinct G Proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The dopamine-D2S receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "coupled to inhibition of adenylyl cyclase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1948027:Coupled [Functional Concept]
   753   C3463820:Inhibition [Activity]
   719 E C0010222:couple [Family Group]

Phrase: "in a wide variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(13,"

Phrase: "14,"

Phrase: "39-41"

Phrase: ")."
Processing 00000000.tx.228: Indeed, inhibition of adenylyl cyclase by receptors that couple to Gi/o appears to be a ubiquitous pathway (2, 5, 6). 

Phrase: "Indeed,"

Phrase: "inhibition of adenylyl cyclase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "couple to Gi/o"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010222:couple [Family Group]
   770   C1948027:Couple [Functional Concept]
   770   C3539617:GI [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a ubiquitous pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.229: In intact cells, adenylyl cyclase can exist in at least three states: basal, forskolin-stimulated, or Gs-stimulated (36). 

Phrase: "In intact cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "adenylyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "exist in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2987476:Exist [Conceptual Entity]

Phrase: "at least three states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: ":"

Phrase: "basal, forskolin-stimulated,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "Gs-"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.230: In Ltk cells, the D2S receptor inhibits cAMP production stimulated by either forskolin or PGE1, but does not inhibit the basal level of cAMP level (Fig. 2, (21)). 

Phrase: "In Ltk cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cAMP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "stimulated by either forskolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "PGE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the basal level of cAMP level"

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "(21"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.231: By contrast, in pituitary cells the D2S receptor inhibits all three states, i.e. basal, forskolin-stimulated, and vasoactive intestinal peptide-stimulated cAMP accumulation (13, 14, 39). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in pituitary cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0229535:Pituitary cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "all three states,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "i.e. basal, forskolin-stimulated,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "vasoactive intestinal peptide-stimulated cAMP accumulation"

Phrase: "(13,"

Phrase: "14,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.232: The basal levels of cAMP are at least 5-fold lower in Ltk fibroblast cells as compared with GH4C1 pituitary cells (34), and perhaps it is already at a minimum level. 

Phrase: "The basal levels of cAMP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are at least 5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332462:Fold [Spatial Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "lower in Ltk fibroblast cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "as"

Phrase: "compared with GH4C1 pituitary cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0229535:Pituitary cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "perhaps"

Phrase: "it"

Phrase: "is"

Phrase: "already at a minimum level."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1524031:Minimum [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.233: Furthermore, our results show that Ltk cells have an undetectable level of ACV, and ACII and IV are weakly expressed (Table I). 

Phrase: "Furthermore,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Ltk cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "an undetectable level of ACV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ACII"

Phrase: "and"

Phrase: "IV"

Phrase: "are"

Phrase: "weakly"

Phrase: "expressed"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.234: This could explain why D2S receptor activation induced no change in basal cAMP production in LD2S cells. 

Phrase: "This"

Phrase: "could"

Phrase: "explain"

Phrase: "why D2S receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514758:Receptor Activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "no change in basal cAMP production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.235: For example, the dopamine-D3 receptor appears to couple exclusively to ACV (42). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the dopamine-D3 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0082341:dopamine D3 receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "exclusively to ACV (42"

Phrase: ")."
Processing 00000000.tx.236: To address the G protein specificity of D2S receptor signaling, LD2S cells were transfected stably with individual PTX-insensitive mutants of Gi/o subtypes and treated with PTX to inactivate endogenous Gi/o proteins. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the G protein specificity of D2S receptor signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]

Phrase: "LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "stably with individual PTX-insensitive mutants of Gi/o subtypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   738   C0027361:Individual [Population Group]
   738   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   738   C0043167:Pertussis [Disease or Syndrome]
   738   C0237401:Individual [Human]
   738   C0449560:subtypes [Classification]
   738   C0596988:mutants [Cell or Molecular Dysfunction]
   738   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "treated with PTX to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0043167:Pertussis [Disease or Syndrome]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "inactivate"

Phrase: "endogenous Gi/o proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.237: When stimulated by forskolin, inhibition of cAMP accumulation by D2S receptor activation is mediated exclusively through the Gi2 subtype (Fig. 3). 

Phrase: "When"

Phrase: "stimulated by forskolin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "inhibition of cAMP accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by D2S receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "exclusively through the Gi2 subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:Subtype [Classification]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.238: This agrees with findings in pituitary cells. 

Phrase: "This"

Phrase: "agrees with findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C2607943:findings [Functional Concept]
   790   C2926606:Findings [Clinical Attribute]
   790   C3539655:Findings [Intellectual Product]
   790   C3641827:Agree [Intellectual Product]
   756 E C0037088:Finding [Sign or Symptom]
   756 E C0243095:Finding [Finding]
   756 E C2825141:Finding [Finding]

Phrase: "in pituitary cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0229535:Pituitary cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.239: Using antibodies to Gi/o subunits, Izenwasser and Cote (43) have reported that inhibition of cAMP accumulation by D2 receptors in pituitary tumor cells utilizes Gi1 and/or Gi2, since their antibody detects both subtypes equally. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to Gi/o subunits,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Izenwasser"

Phrase: "and"

Phrase: "Cote"

Phrase: "(43"

Phrase: ")"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that inhibition of cAMP accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by D2 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058698:d2 receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in pituitary tumor cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0431085:Tumor cells [Cell]
   896   C0229535:Pituitary cell [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0032019:Pituitary tumor [Neoplastic Process]

Phrase: "utilizes"

Phrase: "Gi1"

Phrase: "and/or"

Phrase: "Gi2,"

Phrase: "since"

Phrase: "their antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "both subtypes equally."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]
Processing 00000000.tx.240: Furthermore, using PTX-insensitive mutants, Senogles (39) has shown that in GH4C1 cells expressing D2S receptor, D2S inhibition of forskolin-induced adenylyl cyclase is routed through Gi2. 

Phrase: "Furthermore,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PTX-insensitive mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "Senogles"

Phrase: "(39"

Phrase: ")"

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in GH4C1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "D2S receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "D2S inhibition of forskolin-induced adenylyl cyclase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "routed through Gi2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0013153:ROUTE [Functional Concept]
   756   C0449444:Route [Spatial Concept]
   756   C1879941:ROUTE [Intellectual Product]
Processing 00000000.tx.241: Our results indicate that in Ltk fibroblast cells, the D2S receptor couples preferentially to the Gi2 subtype to inhibit activation of adenylyl cyclase by forskolin. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that in Ltk fibroblast cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0016030:cells fibroblast [Cell]
           Fibroblast
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "couples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:Couples [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "preferentially to the Gi2 subtype to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449560:Subtype [Classification]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "activation of adenylyl cyclase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C1155418:adenylyl cyclase activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "by forskolin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.242: On the other hand, inhibition of PGE1-stimulated cAMP accumulation, a Gs-coupled AC pathway, by D2S receptor activation was mediated through Gi3 in the LD2S cells, and not by Gi2 as for forskolin (Fig. 4). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "inhibition of PGE1-stimulated cAMP accumulation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "a Gs-coupled AC pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "by D2S receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "mediated through Gi3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "in the LD2S cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "not by Gi2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "as for forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.243: This indicates that D2S receptor utilizes distinct Gi proteins to mediate inhibition of AC depending on the pathway of activation of AC. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "utilizes"

Phrase: "distinct Gi proteins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C3539617:GI [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inhibition of AC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "depending on the pathway of activation of AC."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C1412573:AC [Gene or Genome]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1879547:Activation [Activity]
   744   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   744   C3539770:AC [Gene or Genome]
   711   C0725813:depend [Medical Device]
Processing 00000000.tx.244: This is consistent with previous findings in GH4C1 pituitary cells, in which antisense depletion of Gi2 only marginally reduced D2S-mediated inhibition of vasoactive intestinal peptide-stimulated cAMP levels (Gs-coupled), but completely blocked D2S-mediated inhibition of basal cAMP level (14). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in GH4C1 pituitary cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0229535:Pituitary cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in which antisense depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "of Gi2 only marginally reduced D2S-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0021467:Inhibition [Mental Process]
   795   C0021469:Inhibition [Molecular Function]
   795   C1628982:% inhibition [Quantitative Concept]
   795   C3463820:Inhibition [Activity]
   724 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of vasoactive intestinal peptide-stimulated cAMP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Gs-"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "completely blocked D2S-mediated inhibition of basal cAMP level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.245: Interestingly, the coupling of other receptor subtypes (e.g. somatostatin or muscarinic-M4) to inhibition of vasoactive intestinal peptide-induced cAMP was completely blocked by depletion of Gi2. 

Phrase: "Interestingly,"

Phrase: "the coupling of other receptor subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0597359:receptor coupling [Molecular Function]
   753   C1948027:Coupling [Functional Concept]

Phrase: "("

Phrase: "e.g. somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "or"

Phrase: "muscarinic-M4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1561479:M4 [Intellectual Product]

Phrase: ")"

Phrase: "to inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of vasoactive intestinal peptide-induced cAMP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   717   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   717   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by depletion of Gi2."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0333668:Depletion [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.246: Thus, Gi2 plays an important role in D2S coupling to both basal and forskolin-induced AC, but not in coupling to Gs-stimulated AC in both transfected GH4C1 and Ltk cells. 

Phrase: "Thus,"

Phrase: "Gi2"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in D2S coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "to both basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "forskolin-induced AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "but"

Phrase: "not in coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1518422:Not [Functional Concept]
   790   C1948027:Coupling [Functional Concept]

Phrase: "to Gs-stimulated AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "in both transfected GH4C1"

Phrase: "and"

Phrase: "Ltk cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.247: In contrast, Gi3 mediates inhibition of Gs-stimulated AC activity in LD2S cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Gi3"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inhibition of Gs-stimulated AC activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.248: Taken together, these findings provide evidence for a precise regulation of AC activity that is dependent on specific interactions between different activation states of AC and distinct Gai subtypes. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for a precise regulation of AC activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "that"

Phrase: "is"

Phrase: "dependent on specific interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "between different activation states"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1301808:states [Geographic Area]
   827   C1879547:Activation [Activity]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "of AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "and"

Phrase: "distinct Gai subtypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:subtypes [Classification]
Processing 00000000.tx.249: One explanation for the state-dependent specificity of inhibition of AC by Gi is that different subtypes of AC are recruited for forskolin- versus Gs-mediated activation pathways. 

Phrase: "One explanation for the state-dependent specificity of inhibition of AC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0681841:Explanation [Intellectual Product]

Phrase: "by Gi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: "is"

Phrase: "that different subtypes of AC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "recruited for forskolin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "versus"

Phrase: "Gs-mediated activation pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.250: Sutkowski and co-workers (37) have shown that Gs activates ACII more efficaciously than ACI, ACV, or ACVI, whereas forskolin preferentially activates ACI over ACII, ACV, or ACVI. 

Phrase: "Sutkowski"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(37"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Gs"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ACII more efficaciously than ACI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0814206:ACI [Intellectual Product]
   760   C2346870:aCi [Quantitative Concept]

Phrase: "ACV,"

Phrase: "or"

Phrase: "ACVI,"

Phrase: "whereas"

Phrase: "forskolin preferentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ACI over ACII,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0814206:ACI [Intellectual Product]
   790   C2346870:aCi [Quantitative Concept]

Phrase: "ACV,"

Phrase: "or"

Phrase: "ACVI."
Processing 00000000.tx.251: Furthermore, it has been shown that Gi1 inhibits ACV more efficiently than ACI (44). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Gi1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ACV more efficiently than ACI (44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0814206:ACI [Intellectual Product]
   753   C2346870:aCi [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.252: By this interpretation, our results would be consistent with Gi2 having greater activity to inhibit ACI, and Gi3 inhibiting ACII. 

Phrase: "By this interpretation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "consistent with Gi2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "having"

Phrase: "greater activity to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ACI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814206:ACI [Intellectual Product]
  1000   C2346870:aCi [Quantitative Concept]

Phrase: "and"

Phrase: "Gi3"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "ACII."
Processing 00000000.tx.253: However, specific interactions between different Gi and AC subtypes have not been reported. 

Phrase: "However,"

Phrase: "specific interactions between different Gi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "AC subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.254: Another possibility is the state-dependent modulation of individual AC subtypes by distinct Gi proteins. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "the state-dependent modulation of individual AC subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "by distinct Gi proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3539617:GI [Idea or Concept]
Processing 00000000.tx.255: When expressed in Sf9 cells, Gi1 did not inhibit Gs-mediated stimulation of ACI (44). 

Phrase: "When"

Phrase: "expressed in Sf9 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C3494245:Sf9 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "Gi1"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Gs-mediated stimulation of ACI (44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.256: However, when ACI was stimulated by calmodulin or forskolin, Gi1 mediated inhibition of ACI. 

Phrase: "However,"

Phrase: "when"

Phrase: "ACI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814206:ACI [Intellectual Product]
  1000   C2346870:aCi [Quantitative Concept]

Phrase: "was"

Phrase: "stimulated by calmodulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "Gi1"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibition of ACI."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.257: This indicates that the extent of inhibition of a particular AC subtype (ACI) by Gi1 is dependent on the activation pathway. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the extent of inhibition of a particular AC subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439792:Extent [Spatial Concept]

Phrase: "(ACI) by Gi1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0814206:ACI [Intellectual Product]
   790   C2346870:aCi [Quantitative Concept]

Phrase: "is"

Phrase: "dependent on the activation pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.258: Following D2S receptor activation, Gi2 may also preferentially inhibit the forskolin-activated state in AC subtypes that predominate in Ltk cells, whereas Gi3 preferentially inhibits the Gs-activated state. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "D2S receptor activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]

Phrase: "Gi2"

Phrase: "may"

Phrase: "also preferentially"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the forskolin-activated state in AC subtypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "that"

Phrase: "predominate in Ltk cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0332251:Predominate [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "Gi3 preferentially"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Gs-activated state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
Processing 00000000.tx.259: Distinct conformational changes in AC upon interaction with forskolin or Gs could explain the selective inhibition of Gi subtypes. 

Phrase: "Distinct conformational changes in AC"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0301641:Conformational change [Molecular Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "upon interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Gs"

Phrase: "could"

Phrase: "explain"

Phrase: "the selective inhibition of Gi subtypes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.260: The crystal structure of the catalytic domain of ACII reveals that forskolin binds to two symetric sites to prevent hydration and enhance dimerization of the C1-C2 domains (45). 

Phrase: "The crystal structure of the catalytic domain of ACII"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   742   C0427896:Crystal [Body Substance]
   742   C0678594:Structure [Spatial Concept]
   742   C1533132:Crystal [Body Substance]
   742   C1704641:Crystal [Manufactured Object]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to two symetric sites to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "hydration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321013:Hydration [Finding]

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "dimerization of the C1-C2 domains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.261: The binding site for Gi/o has not been determined, but it may bind to the a2/a3 region of C1a, which is close to the catalytic domain, on the opposite site of the Gs site (46). 

Phrase: "The binding site for Gi/o"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "may"

Phrase: "bind to the a2/a3 region of C1a,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]

Phrase: "which"

Phrase: "is"

Phrase: "close to the catalytic domain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0587267:Close [Functional Concept]

Phrase: "on the opposite site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of the Gs site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.262: In this case, Gi/o protein could alter the preferable alignment by blocking the "counterclockwise" rotation of C1 (47). 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "Gi/o protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the preferable alignment by blocking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706765:Alignment [Quantitative Concept]

Phrase: "the ""counterclockwise"" rotation of C1 (47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035868:Rotation [Functional Concept]
   753   C0677597:Rotation [Functional Concept]

Phrase: ")."
Processing 00000000.tx.263: In the forskolin-bound conformation, AC may preferentially recognize specific Gi/o protein subtypes distinct from those recognized by the Gs-bound conformation of AC. 

Phrase: "In the forskolin-bound conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "may"

Phrase: "preferentially"

Phrase: "recognize"

Phrase: "specific Gi/o protein subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449560:subtypes [Classification]

Phrase: "distinct from those"

Phrase: "recognized by the Gs-bound conformation of AC."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0026377:Conformation [Spatial Concept]
   744   C0332297:bound [Spatial Concept]
           Bounded by
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1412573:AC [Gene or Genome]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   744   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   744   C3539770:AC [Gene or Genome]
Processing 00000000.tx.264: Further structural studies may reveal the molecular basis for state-dependent Gi protein selectivity in inhibition of AC. 

Phrase: "Further structural studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0678594:Structural [Spatial Concept]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the molecular basis for state-dependent Gi protein selectivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1853126:MOLECULAR BASIS [Idea or Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "in inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of AC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]
Processing 00000000.tx.265: G and Calcium Mobilization-- In LD2S cells transfected with single or pairs of PTX-insensitive Gi/o proteins cDNAs to yield a greater than 2-fold protein expression, dopamine failed to induce calcium mobilization after PTX treatment, suggesting that G subunits plays a minor or secondary role in this pathway. 

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Calcium Mobilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596233:calcium mobilization [Cell Function]
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0037179:Single [Population Group]
   790   C0087136:single [Finding]
   790   C0205171:Single [Quantitative Concept]

Phrase: "or"

Phrase: "pairs of PTX-insensitive Gi/o proteins cDNAs to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   739   C0043167:Pertussis [Disease or Syndrome]
   739   C1709450:Pair [Qualitative Concept]
   739   C3539617:GI [Idea or Concept]
   706   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yield"

Phrase: "a greater than 2-fold protein expression,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439093:Greater Than [Quantitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "calcium mobilization after PTX treatment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596233:calcium mobilization [Cell Function]
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that G subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a minor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026193:Minor [Population Group]
  1000   C0205165:Minor [Qualitative Concept]

Phrase: "or"

Phrase: "secondary role in this pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.266: On the other hand, inhibition of G signaling in LD2S cells expressing GRK-CT correlated with an inhibition of D2S-induced calcium mobilization, indicating that this process is mediated through G subunits rather than the G subunit. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "inhibition of G signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in LD2S cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "GRK-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "correlated with an inhibition of D2S-induced calcium mobilization,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0596233:calcium mobilization [Cell Function]
   742   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0006726:Calcium [Inorganic Chemical]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   742   C0205263:Induced [Functional Concept]
   742   C0300926:mobilization [Functional Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1707520:Correlated [Qualitative Concept]
   742   C2936886:Calcium [Pharmacologic Substance]
   742   C3463820:Inhibition [Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "mediated through G subunits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0439267:g% [Quantitative Concept]
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "rather than"

Phrase: "the G subunit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.267: This result is consistent with the fact that G subunits of Gi/o proteins can activate PLC-2 and PLC-3 (5). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that G subunits of Gi/o proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   809   C0086706:G-Protein, Gi Subunit [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   714   C1711351:Subunit [Quantitative Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "PLC-2"

Phrase: "and"

Phrase: "PLC-3"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.268: Recent results indicate that the D2S receptor increases calcium mobilization in LD2S cells via activation of PLC-2 (33), implicating G-signaling in the calcium mobilization pathway. 

Phrase: "Recent results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the D2S receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calcium mobilization in LD2S cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596233:calcium mobilization [Cell Function]
   760   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   760   C0300926:mobilization [Functional Concept]

Phrase: "via activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of PLC-2"

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "implicating"

Phrase: "G-signaling in the calcium mobilization pathway."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C2984272:Calcium signaling pathway [Functional Concept]
   774   C0037080:pathway signaling [Molecular Function]
   774   C0037083:signaling pathway [Cell Function]
           Signaling
   774   C0086982:Signaling Pathway [Molecular Function]
   774   C0600431:Calcium Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]
Processing 00000000.tx.269: The lack of activity of individual G subunits to mediate calcium mobilization was partly unexpected. 

Phrase: "The lack of activity of individual G subunits to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332268:lack [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "calcium mobilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596233:calcium mobilization [Cell Function]
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]

Phrase: "was"

Phrase: "partly unexpected."
Processing 00000000.tx.270: In NG108-15 neuroblastoma cells, PTX-insensitive Go did mediate coupling to inhibition of calcium channel activation (25), a G-mediated response (5). 

Phrase: "In NG108-15 neuroblastoma cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "PTX-insensitive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]
   755   C0237677:Insensitivity [Finding]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "did"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "coupling to inhibition of calcium channel activation"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   804   C1516145:Calcium Channel Inhibition [Cell Function]
   778   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0439799:Channel [Spatial Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1706095:Channel [Conceptual Entity]
   748   C1879547:Activation [Activity]
   748   C1948027:Coupling [Functional Concept]
   748   C2936886:Calcium [Pharmacologic Substance]
   748   C3463820:Inhibition [Activity]
   714 E C0010222:couple [Family Group]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "a G-mediated response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0870868:mediated response [Mental Process]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.271: It has been estimated that a 10-fold higher amount of G is required to activate PLC-2 in vitro than is required for Gi-mediated activation of AC (48). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that a 10-fold higher amount of G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "PLC-2 in vitro than"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "is"

Phrase: "required for Gi-mediated activation of AC (48"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C1412573:AC [Gene or Genome]
   744   C1514873:Required [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   744   C3539617:GI [Idea or Concept]
   744   C3539770:AC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.272: It may be that multiple Gi/Go subtypes, rather than a single subtype, must be activated to release sufficient G subunits to induce calcium mobilization in LD2S cells. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "that multiple Gi/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "subtypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449560:subtypes [Classification]

Phrase: "rather than"

Phrase: "a single subtype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:Subtype [Classification]

Phrase: "must"

Phrase: "be"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "sufficient G subunits to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1711351:Subunit [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "calcium mobilization in LD2S cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596233:calcium mobilization [Cell Function]
   760   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   760   C0300926:mobilization [Functional Concept]
Processing 00000000.tx.273: Conclusion-- The dopamine D2S receptor couples to Gi2 to inhibit forskolin-induced cAMP production. 

Phrase: "Conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The dopamine D2S receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "couples to Gi2 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010222:Couples [Family Group]
   770   C1948027:Couple [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "forskolin-induced cAMP production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]
Processing 00000000.tx.274: On the other hand, when AC is activated by a Gs-coupled receptor (PGE1 receptor), dopamine-induced inhibition is mediated by Gi3. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "when"

Phrase: "AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "is"

Phrase: "activated by a Gs-coupled receptor"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1879547:Activated [Activity]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]
   719 E C1515877:Activate [Functional Concept]

Phrase: "(PGE1 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: ","

Phrase: "dopamine-induced inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by Gi3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.275: Furthermore, D2S-induced increase in [Ca2+]i in LD2S cells is not dependent on any particular Gi/o subtype, but is dependent on mobilization of G subunit. 

Phrase: "Furthermore,"

Phrase: "D2S-induced increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i in LD2S cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "not dependent on any particular Gi/o subtype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "but"

Phrase: "is"

Phrase: "dependent on mobilization of G subunit."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.276: Therefore, the dopamine D2S receptor utilizes different Gi/o protein subunits to regulate a diversity of effector functions within the cell. 

Phrase: "Therefore,"

Phrase: "the dopamine D2S receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0962411:dopamine D2S receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C0034798:Dopamine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "utilizes"

Phrase: "different Gi/o protein subunits to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "regulate"

Phrase: "a diversity of effector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "functions within the cell."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   819   C0007613:Cell Function [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1705273:Function [Intellectual Product]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.277: Moreover, this study shows that the PTX-insensitive Gi/o mutants provide useful tools for the dissection of G protein coupling to receptors.  

Phrase: "Moreover,"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the PTX-insensitive Gi/o mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "useful tools for the dissection of G protein coupling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0871532:tools use [Finding]
   708   C0336791:Tool [Manufactured Object]
   708   C2827396:Tool [Manufactured Object]

Phrase: "to receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.278: ACKNOWLEDGEMENTS We thank Christine Forget for excellent technical assistance with cAMP assays. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Christine"

Phrase: "Forget for excellent technical assistance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018896:Assistance [Social Behavior]
   760   C0449851:Technical [Functional Concept]
   760   C0598853:forget [Mental or Behavioral Dysfunction]
   760   C1548784:Excellent [Qualitative Concept]
   760   C1961136:Excellent [Qualitative Concept]

Phrase: "with cAMP assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.279: We also acknowledge the helpful editorial comments of Dr. 

Phrase: "We also"

Phrase: "acknowledge"

Phrase: "the helpful editorial comments of Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0282411:Editorial Comment [Intellectual Product]
           Comments
   753   C0947611:comments [Intellectual Product]
   753   C1705247:Comments [Conceptual Entity]
Processing 00000000.tx.280: Maribeth Lazzaro.  

Phrase: "Maribeth Lazzaro."
Processing 00000000.tx.281: FOOTNOTES * This work was supported in part by grants from the Medical Research Council of Canada (to P.R.A.) and National Cancer Institute of Canada (to P.R.A).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from the Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "of Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "("

Phrase: "to P.R.A.)"

Phrase: "and"

Phrase: "National Cancer Institute of Canada"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1513884:National Cancer Institute of Canada [Organization]
   862   C1513882:National Cancer Institute [Health Care Related Organization]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0021622:institute [Organization]
   760   C0998265:Cancer [Eukaryote]
   760   C1272753:Institute [Idea or Concept]
   760   C1306459:Cancer [Finding]
   760   C3245503:national [Intellectual Product]

Phrase: "("

Phrase: "to P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.282: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.283: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.284: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.285: Supported by the Ministry of Health of Iran and Schizophrenia Society of Canada. 

Phrase: "Supported by the Ministry of Health of Iran"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0018684:Health [Idea or Concept]
   744   C0022065:Iran [Geographic Area]
   744   C1521721:Supported [Conceptual Entity]
   711 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Schizophrenia Society of Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0037455:society [Organization]
Processing 00000000.tx.286: Novartis/MRC/Michael Smith Chair in Neurosciences. 

Phrase: "Novartis/MRC/Michael Smith Chair in Neurosciences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0179847:chair [Medical Device]
   748   C1524106:Chair [Professional or Occupational Group]
Processing 00000000.tx.287: To whom correspondence should be addressed: Neuroscience Research Institute, 451Smyth Rd., Rm. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Neuroscience Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "451Smyth Rd.,"

Phrase: "Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]
Processing 00000000.tx.288: 2464,Ottawa K1H 8M5, Canada. 

Phrase: "2464,"

Phrase: "Ottawa K1H 8M5,"

Phrase: "Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.289: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.290: 613-562-5800(ext. 

Phrase: "613-562-5800"

Phrase: "(ext."
Processing 00000000.tx.291: 8307); 

Phrase: "8307"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.292: Fax: 613-562-5403; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "613-562-5403"

Phrase: ";"
Processing 00000000.tx.293: E-mail: palbert{at}uottawa.ca .  ABBREVIATIONS The abbreviations used are: G protein, guanine nucleotide-binding protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "palbert{at}uottawa.ca .  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "G protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "guanine nucleotide-binding protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0086376:Guanine Nucleotide Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0596637:guanine nucleotide binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1817325:guanine binding [Molecular Function]
   861   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.294: AC, adenylyl cyclase; 

Phrase: "AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "adenylyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.295: [Ca2+]i, intracellular calcium concentration; 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "intracellular calcium concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ";"
Processing 00000000.tx.296: FBS, fetal bovine serum; 

Phrase: "FBS,"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.297: PTX, pertussis toxin; 

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "pertussis toxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.298: G-PTX, G protein insensitive to PTX; 

Phrase: "G-PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "G protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "insensitive to PTX"

Phrase: ";"
Processing 00000000.tx.299: HBBS, Hepes-buffered balanced salt solution; 

Phrase: "HBBS,"

Phrase: "Hepes-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "balanced salt solution"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0037633:Solution [Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   827   C0525069:Solution [Biomedical or Dental Material]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.300: MEM, minimum Eagles's medium; 

Phrase: "MEM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "minimum Eagles's medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.301: PLC, phospholipase C; 

Phrase: "PLC,"

Phrase: "phospholipase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.302: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.303: PGE1, prostaglandin E1.  

Phrase: "PGE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:PGE1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:PGE1 [Laboratory Procedure]

Phrase: "prostaglandin E1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002335:Prostaglandin E1 [Eicosanoid,Pharmacologic Substance]
  1000   C3538799:Prostaglandin E1 [Laboratory Procedure]
Processing 00000000.tx.304: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Neer, E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Neer,"

Phrase: "E."
Processing 00000000.tx.305: J. 

Phrase: "J."
Processing 00000000.tx.306: (1995) Cell 80, 249-257[Medline] [OrderarticleviaInfotrieve] Bourne, H. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 80,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "249-257"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bourne,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.307: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.308: (1997) Curr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.309: Opin. 

Phrase: "Opin."
Processing 00000000.tx.310: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.311: 9, 134-142[CrossRef][Medline] [OrderarticleviaInfotrieve] Raymond, J. 

Phrase: "9,"

Phrase: "134-142"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Raymond,"

Phrase: "J."
Processing 00000000.tx.312: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.313: (1995) Am. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.314: J.

Phrase: "J."
Processing 00000000.tx.315: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.316: 38, F141-F158 Birnbaumer, L. 

Phrase: "38,"

Phrase: "F141-F158 Birnbaumer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.317: (1992) Cell 71, 1069-1072[Medline] [OrderarticleviaInfotrieve] Clapham, D. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 71,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1069-1072"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Clapham,"

Phrase: "D."
Processing 00000000.tx.318: E., and Neer, E. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Neer,"

Phrase: "E."
Processing 00000000.tx.319: J. 

Phrase: "J."
Processing 00000000.tx.320: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.321: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.322: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.323: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.324: 37, 167-203[CrossRef][Medline] [OrderarticleviaInfotrieve] Gudermann, T., Kalkbrenner, F., and Schultz, G. 

Phrase: "37,"

Phrase: "167-203"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gudermann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kalkbrenner,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Schultz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.325: (1996) Annu. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.326: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.327: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.328: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.329: 36, 429-459[CrossRef][Medline] [OrderarticleviaInfotrieve] Civelli, O., Bunzow, J. 

Phrase: "36,"

Phrase: "429-459"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Civelli,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Bunzow,"

Phrase: "J."
Processing 00000000.tx.330: R., and Grandy, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Grandy,"

Phrase: "D."
Processing 00000000.tx.331: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.332: (1993) Annu. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.333: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.334: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.335: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.336: 33, 281-307[CrossRef][Medline] [OrderarticleviaInfotrieve] Albert, P. 

Phrase: "33,"

Phrase: "281-307"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.337: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: (1994) Vitam. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Vitam."
Processing 00000000.tx.339: Horm. 

Phrase: "Horm."
Processing 00000000.tx.340: 48, 59-109[Medline] [OrderarticleviaInfotrieve] Castellano, M. 

Phrase: "48,"

Phrase: "59-109"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Castellano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: A., Liu, L. 

Phrase: "A.,"

Phrase: "Liu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.342: X., Monsma, F. 

Phrase: "X.,"

Phrase: "Monsma,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.343: J., Sibley, D. 

Phrase: "J.,"

Phrase: "Sibley,"

Phrase: "D."
Processing 00000000.tx.344: R., Kapatos, G., and Chiodo, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kapatos,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Chiodo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.345: A. 

Phrase: "A."
Processing 00000000.tx.346: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.347: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.348: 44, 649-656[Abstract] Einhorn, L. 

Phrase: "44,"

Phrase: "649-656"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Einhorn,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.349: C., Gregerson, K. 

Phrase: "C., Gregerson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.350: A., and Oxford, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Oxford,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.351: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.353: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.354: 11, 3727-3737[Abstract] Lledo, P. 

Phrase: "11,"

Phrase: "3727-3737"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lledo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.355: M., Homburger, V., Bockaert, J., and Vincent, J. 

Phrase: "M."

Phrase: ","

Phrase: "Homburger,"

Phrase: "V.,"

Phrase: "Bockaert,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.356: D. 

Phrase: "D."
Processing 00000000.tx.357: (1992) Neuron 8, 455-463[Medline] [OrderarticleviaInfotrieve] Memo, M., Pizzi, M., Belloni, M., Benarese, M., and Spano, P. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuron 8,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "455-463"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Memo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422348:MEMO [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Pizzi,"

Phrase: "M."

Phrase: ","

Phrase: "Belloni,"

Phrase: "M."

Phrase: ","

Phrase: "Benarese,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Spano,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.358: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.359: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.360: 59, 1829-1835[Medline] [OrderarticleviaInfotrieve] Albert, P. 

Phrase: "59,"

Phrase: "1829-1835"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.361: R., Neve, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Neve,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.362: A., Bunzow, J. 

Phrase: "A.,"

Phrase: "Bunzow,"

Phrase: "J."
Processing 00000000.tx.363: R., and Civelli, O. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Civelli,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.364: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.365: Biol. 

Phrase: "Biol."
Processing 00000000.tx.366: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.367: 265, 2098-2104[Abstract/Free FullText] Liu, Y. 

Phrase: "265,"

Phrase: "2098-2104"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "Y."
Processing 00000000.tx.368: F., Jakobs, K. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jakobs,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.369: H., Rasenick, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rasenick,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: M., and Albert, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.371: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.372: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.373: Biol. 

Phrase: "Biol."
Processing 00000000.tx.374: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.375: 269, 13880-13886[Abstract/Free FullText] Senogles, S. 

Phrase: "269,"

Phrase: "13880-13886"

Phrase: "[Abstract/Free FullText"

Phrase: "] Senogles,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: E. 

Phrase: "E."
Processing 00000000.tx.377: (1994) Endocrinology 134, 783-789[Abstract] Vallar, L., Muca, C., Magni, M., Albert, P., Bunzow, J., Meldolesi, J., and Civelli, O. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Endocrinology 134,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "783-789"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vallar,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Muca,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Magni,"

Phrase: "M."

Phrase: ","

Phrase: "Albert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bunzow,"

Phrase: "J.,"

Phrase: "Meldolesi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Civelli,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.378: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.379: Biol. 

Phrase: "Biol."
Processing 00000000.tx.380: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.381: 265, 10320-10326[Abstract/Free FullText] Lew, A. 

Phrase: "265,"

Phrase: "10320-10326"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lew,"

Phrase: "A."
Processing 00000000.tx.382: M., and Elsholtz, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Elsholtz,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.383: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.384: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.385: Biol. 

Phrase: "Biol."
Processing 00000000.tx.386: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.387: 270, 7156-7160[Abstract/Free FullText] Elsholtz, H. 

Phrase: "270,"

Phrase: "7156-7160"

Phrase: "[Abstract/Free FullText"

Phrase: "] Elsholtz,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.388: P., Lew, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lew,"

Phrase: "A."
Processing 00000000.tx.389: M., Albert, P. 

Phrase: "M."

Phrase: ","

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.390: R., and Sundmark, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sundmark,"

Phrase: "V."
Processing 00000000.tx.391: C. 

Phrase: "C."
Processing 00000000.tx.392: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.395: 266, 22919-22925[Abstract/Free FullText] Huff, R. 

Phrase: "266,"

Phrase: "22919-22925"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huff,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0566520:huff [Finding]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.396: M., and Lajiness, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lajiness,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.397: E. 

Phrase: "E."
Processing 00000000.tx.398: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.399: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.400: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.401: 18B, 220 Lajiness, M. 

Phrase: "18B,"

Phrase: "220 Lajiness,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: E., Chio, C. 

Phrase: "E.,"

Phrase: "Chio,"

Phrase: "C."
Processing 00000000.tx.403: L., and Huff, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Huff,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0566520:huff [Finding]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.406: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.407: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.408: Therap. 

Phrase: "Therap."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1024573:therap [Fish]
Processing 00000000.tx.409: 267, 1573-1581[Abstract] Liu, Y. 

Phrase: "267,"

Phrase: "1573-1581"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liu,"

Phrase: "Y."
Processing 00000000.tx.410: F., Civelli, O., Grandy, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Civelli,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Grandy,"

Phrase: "D."
Processing 00000000.tx.411: K., and Albert, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.412: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.413: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.414: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.415: 59, 2311-2317[Medline] [OrderarticleviaInfotrieve] Hayes, G., Biden, T. 

Phrase: "59,"

Phrase: "2311-2317"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hayes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1010099:Biden [Plant]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.416: J., Selbie, L. 

Phrase: "J.,"

Phrase: "Selbie,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.417: A., and Shine, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Shine,"

Phrase: "J."
Processing 00000000.tx.418: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.419: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.420: 6, 920-926[Abstract] Tang, L., Todd, R. 

Phrase: "6,"

Phrase: "920-926"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Todd,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.421: D., Heller, A., and O'Malley, K. 

Phrase: "D."

Phrase: ","

Phrase: "Heller,"

Phrase: "A.,"

Phrase: "and"

Phrase: "O'Malley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.423: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.424: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.425: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.426: Therap. 

Phrase: "Therap."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1024573:therap [Fish]
Processing 00000000.tx.427: 268, 495-502[Abstract] Yamane, H. 

Phrase: "268,"

Phrase: "495-502"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yamane,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.428: K., and Fung, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Fung,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.429: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.430: (1993) Annu. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.431: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.432: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.433: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.434: 33, 201-241[CrossRef][Medline] [OrderarticleviaInfotrieve] Taussig, R., Sanchez, S., RIfo, M., Gilma, A. 

Phrase: "33,"

Phrase: "201-241"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Taussig,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sanchez,"

Phrase: "S."

Phrase: ","

Phrase: "RIfo,"

Phrase: "M."

Phrase: ","

Phrase: "Gilma,"

Phrase: "A."
Processing 00000000.tx.435: G., and Belardeti, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Belardeti,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.436: (1992) Neuron 8, 799-809[Medline] [OrderarticleviaInfotrieve] Chuprun, J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuron 8,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "799-809"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chuprun,"

Phrase: "J."
Processing 00000000.tx.437: K., Raymond, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Raymond,"

Phrase: "J."
Processing 00000000.tx.438: R., and Blackshear, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Blackshear,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.439: J. 

Phrase: "J."
Processing 00000000.tx.440: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Biol. 

Phrase: "Biol."
Processing 00000000.tx.442: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.443: 272, 773-781[Abstract/Free FullText] Ghahremani, M. 

Phrase: "272,"

Phrase: "773-781"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghahremani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: H., and Albert, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.446: (1995) Proceeding of the Society for Neuroscience, Vol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proceeding of the Society"

Phrase: "for Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.447: 21, p. 

Phrase: "21,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.448: 1863, Society for Neuroscience, San Diego Hunt, T. 

Phrase: "1863,"

Phrase: "Society for Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037455:society [Organization]

Phrase: "San Diego Hunt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.449: W., Carroll, R. 

Phrase: "W., Carroll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.450: C., and Peralta, E. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Peralta,"

Phrase: "E."
Processing 00000000.tx.451: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.452: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.453: Biol. 

Phrase: "Biol."
Processing 00000000.tx.454: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.455: 269, 29565-29570[Abstract/Free FullText] Jones, D. 

Phrase: "269,"

Phrase: "29565-29570"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.456: T., and Reed, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Reed,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.458: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.459: Biol. 

Phrase: "Biol."
Processing 00000000.tx.460: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.461: 262, 14241-14249[Abstract/Free FullText] Lembo, P. 

Phrase: "262,"

Phrase: "14241-14249"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lembo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.462: M.C., Ghahremani, M. 

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ghahremani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: H., and Albert, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.464: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.466: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.467: 13, 138-147[Abstract/Free FullText] Kozak, M. 

Phrase: "13,"

Phrase: "138-147"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kozak,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: (1986) Cell 44, 383-292 Sambrook, J., Fritsch, E. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Cell 44,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "383-292 Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E."
Processing 00000000.tx.469: F., and Maniatis, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.470: (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY Morris, S. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual, 2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Morris,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.471: J., Kriz, R., and Albert, P. 

Phrase: "J.,"

Phrase: "Kriz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.472: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.473: (1996) Proceeding of the Society for Neuroscience, Vol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proceeding of the Society"

Phrase: "for Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.474: 22, Society for Neuroscience, Washington, D.C. 

Phrase: "22,"

Phrase: "Society for Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037455:society [Organization]

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "D.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.475: Liu, Y. 

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.476: F., and Albert, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Albert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.477: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.478: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.479: Biol. 

Phrase: "Biol."
Processing 00000000.tx.480: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.481: 266, 23689-23697[Abstract/Free FullText] Nevo, I., Avidorreiss, T., Levy, R., Bayewitch, M., Heldman, E., and Vogel, Z. 

Phrase: "266,"

Phrase: "23689-23697"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nevo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Avidorreiss,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levy,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bayewitch,"

Phrase: "M."

Phrase: ","

Phrase: "Heldman,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Vogel,"

Phrase: "Z."
Processing 00000000.tx.482: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.483: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.484: 54, 419-426[Abstract/Free FullText] Sunahara, R. 

Phrase: "54,"

Phrase: "419-426"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sunahara,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: K., Dessauer, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dessauer,"

Phrase: "C."
Processing 00000000.tx.486: W., and Gilman, A. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Gilman,"

Phrase: "A."
Processing 00000000.tx.487: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.488: (1996) Annu. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.489: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.490: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.491: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.492: 36, 461-480[CrossRef][Medline] [OrderarticleviaInfotrieve] Sutkowski, E. 

Phrase: "36,"

Phrase: "461-480"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sutkowski,"

Phrase: "E."
Processing 00000000.tx.493: M., Tang, W. 

Phrase: "M."

Phrase: ","

Phrase: "Tang,"

Phrase: "W."
Processing 00000000.tx.494: J., Broome, C. 

Phrase: "J.,"

Phrase: "Broome,"

Phrase: "C."
Processing 00000000.tx.495: W., Robbins, J. 

Phrase: "W., Robbins,"

Phrase: "J."
Processing 00000000.tx.496: D., and Seamon, K. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Seamon,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.497: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.498: (1994) Biochemistry 33, 12852-12859[Medline] [OrderarticleviaInfotrieve] Koch, W. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "12852-12859"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koch,"

Phrase: "W."
Processing 00000000.tx.499: J., Hawes, B. 

Phrase: "J.,"

Phrase: "Hawes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.500: E., Inglese, J., Luttrell, L. 

Phrase: "E.,"

Phrase: "Inglese,"

Phrase: "J.,"

Phrase: "Luttrell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.501: M., and Lefkowitz, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lefkowitz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: J. 

Phrase: "J."
Processing 00000000.tx.503: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.504: Biol. 

Phrase: "Biol."
Processing 00000000.tx.505: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.506: 269, 6193-6197[Abstract/Free FullText] Senogles, S. 

Phrase: "269,"

Phrase: "6193-6197"

Phrase: "[Abstract/Free FullText"

Phrase: "] Senogles,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.507: E. 

Phrase: "E."
Processing 00000000.tx.508: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.509: Biol. 

Phrase: "Biol."
Processing 00000000.tx.510: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.511: 269, 23120-23127[Abstract/Free FullText] Montmayeur, J. 

Phrase: "269,"

Phrase: "23120-23127"

Phrase: "[Abstract/Free FullText"

Phrase: "] Montmayeur,"

Phrase: "J."
Processing 00000000.tx.512: P., Guiramand, J., and Borrelli, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Guiramand,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Borrelli,"

Phrase: "E."
Processing 00000000.tx.513: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.514: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.515: 7, 161-170[Abstract] Malek, D., Munch, G., and Palm, D. 

Phrase: "7,"

Phrase: "161-170"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Malek,"

Phrase: "D."

Phrase: ","

Phrase: "Munch"

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Palm,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0230373:Palm [Body Location or Region]
  1000   C0817662:Palm [Body Location or Region]
  1000   C1418262:PALM [Gene or Genome]
   944 E C0230374:Thenar [Body Location or Region]
   916 E C0682477:palms [Plant]

Phrase: "D."
Processing 00000000.tx.516: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.517: 325, 215-219[CrossRef][Medline] [OrderarticleviaInfotrieve] Robinson, S. 

Phrase: "325,"

Phrase: "215-219"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: W., and Caron, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Caron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.520: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.521: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.522: 52, 508-514[Abstract/Free FullText] Izenwasser, S., and Cote, T. 

Phrase: "52,"

Phrase: "508-514"

Phrase: "[Abstract/Free FullText"

Phrase: "] Izenwasser,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cote,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.523: E. 

Phrase: "E."
Processing 00000000.tx.524: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.525: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.526: 64, 1614-1621[Medline] [OrderarticleviaInfotrieve] Taussig, R., Iniguez-Lluhi, J. 

Phrase: "64,"

Phrase: "1614-1621"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Taussig,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Iniguez-Lluhi,"

Phrase: "J."
Processing 00000000.tx.527: A., and Gilman, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Gilman,"

Phrase: "A."
Processing 00000000.tx.528: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.529: (1993) Science 261, 218-221[Medline] [OrderarticleviaInfotrieve] Zhang, G., Liu, Y., Ruoho, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "218-221"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liu,"

Phrase: "Y.,"

Phrase: "Ruoho,"

Phrase: "A."
Processing 00000000.tx.530: E., and Hurley, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hurley,"

Phrase: "J."
Processing 00000000.tx.531: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.532: (1997) Nature 386, 247-253[CrossRef][Medline] [OrderarticleviaInfotrieve] Yan, S. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 386,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "247-253"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.533: Z., Hahn, D., Huang, Z. 

Phrase: "Z.,"

Phrase: "Hahn,"

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "Z."
Processing 00000000.tx.534: H., and Tang, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tang,"

Phrase: "W."
Processing 00000000.tx.535: J. 

Phrase: "J."
Processing 00000000.tx.536: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Biol. 

Phrase: "Biol."
Processing 00000000.tx.538: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.539: 271, 10941-10945[Abstract/Free FullText] Tang, W. 

Phrase: "271,"

Phrase: "10941-10945"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tang,"

Phrase: "W."
Processing 00000000.tx.540: J., and Hurley, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Hurley,"

Phrase: "J."
Processing 00000000.tx.541: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.542: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.543: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.544: 54, 231-240[Free FullText] Camps, M., Hou, C., Sidiropoulos, D., Stock, J. 

Phrase: "54,"

Phrase: "231-240"

Phrase: "[Free FullText"

Phrase: "] Camps,"

Phrase: "M."

Phrase: ","

Phrase: "Hou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sidiropoulos,"

Phrase: "D."

Phrase: ","

Phrase: "Stock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]

Phrase: "J."
Processing 00000000.tx.545: B., and Jakobs, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jakobs,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.546: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.547: (1992) Eur. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.548: J.

Phrase: "J."
Processing 00000000.tx.549: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.550: 206, 23066-23075 Copyright  1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "206,"

Phrase: "23066-23075 Copyright  1999 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0009993:Copyright [Intellectual Product]
   744   C0037455:society [Organization]
   744   C0596070:American [Population Group]
   744   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

